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Abstract
The mammalian circadian clock and the cell cycle are two major biological oscillators whose
coupling influences cell fate decisions. In the present study, we use a model-driven experi-
mental approach to investigate the interplay between clock and cell cycle components and
the dysregulatory effects of RAS on this coupled system. In particular, we focus on the
Ink4a/Arf locus as one of the bridging clock-cell cycle elements. Upon perturbations by the
rat sarcoma viral oncogene (RAS), differential effects on the circadian phenotype were
observed in wild-type and Ink4a/Arf knock-out mouse embryonic fibroblasts (MEFs), which
could be reproduced by our modelling simulations and correlated with opposing cell cycle
fate decisions. Interestingly, the observed changes can be attributed to in silico phase shifts
in the expression of core-clock elements. A genome-wide analysis revealed a set of differen-
tially expressed genes that form an intricate network with the circadian system with enriched
pathways involved in opposing cell cycle phenotypes. In addition, a machine learning
approach complemented by cell cycle analysis classified the observed cell cycle fate deci-
sions as dependent on Ink4a/Arf and the oncogene RAS and highlighted a putative fine-tun-
ing role of Bmal1 as an elicitor of such processes, ultimately resulting in increased cell
proliferation in the Ink4a/Arf knock-out scenario. This indicates that the dysregulation of the
core-clock might work as an enhancer of RAS-mediated regulation of the cell cycle. Our
combined in silico and in vitro approach highlights the important role of the circadian clock
as an Ink4a/Arf-dependent modulator of oncogene-induced cell fate decisions, reinforcing
its function as a tumour-suppressor and the close interplay between the clock and the cell
cycle network.
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Author summary
In mammals, the circadian clock controls the punctual regulation of biological processes,
which, in turn, affect physiology and behaviour, allowing for the synchronisation of inter-
nal time to environmental light-dark cycles. Malfunctions of the circadian clock are asso-
ciated with pathological phenotypes including cancer. Given the range of molecular time-
dependent processes, including metabolism, DNA repair, and the cell cycle, the clock is
hypothesised to act as a tumour suppressor. With the help of mathematical modelling and
whole-genome analysis combined with machine learning, we investigated the RAS-depen-
dent dysregulation of the circadian clock. We find that the tumour-suppressor Ink4a/Arf
acts as a key mediator of RAS oncogene-induced changes in the circadian system, thereby
mediating the interplay between the clock and the cell cycle.
Introduction
Earth’s rotation within repetitive cycles of 24 hours (h) led to the evolution of an endogenous
timing system across all phyla: the circadian clock, which allows organisms to anticipate and
adapt to environmental changes such as light and darkness. At the molecular level, the genera-
tion of circadian rhythms in each cell is based on a complex interplay of positive and negative
transcriptional/translational feedback loops. In mammals, two main feedback loops have been
dissected in greater detail [1]. In the period (PER)/cryptochrome (CRY) loop, a heterodimer
of the proteins circadian locomotor output cycles kaput (CLOCK) and brain and muscle aryl
hydrocarbon receptor nuclear translocator-like protein (BMAL) drives the expression of genes
from the Per and Cry families. The resulting proteins translocate back to the nucleus, form
complexes, and bind to the CLOCK/BMAL heterodimer, thereby inhibiting their own synthe-
sis. CLOCK/BMAL also induces the transcription of the nuclear receptor gene families reverse
strand of ERBA (Rev-Erb) and RAR-related orphan receptors (Ror) within the ROR/Bmal/
REV-ERB loop. REV-ERB and ROR compete for the binding to ROR response elements
(ROREs) in the promoter region of Bmal1, regulating its transcription in antagonistic ways. By
controlling rhythmic RNA and protein abundance, the cellular endogenous clock regulates cir-
cadian rhythms of a variety of biological processes such as rest/activity cycles, metabolism,
hormone level, immune functions, and the metabolism of drugs [2,3]. Disturbances of the cir-
cadian system are associated with many pathological phenotypes including cancer [4,5],
though the effect of the circadian clock in tumourigenesis is still an issue of ongoing debate.
Several epidemiological studies reported increased occurrence of cancer in long-term shift
workers [6,7], indicating that disrupted circadian rhythms may constitute a cancer risk factor.
However, a causative connection is still disputed [8]. Particularly at the molecular level, there
is a need for further investigation regarding the putative role of the circadian clock in tumouri-
genesis. An oncogenic-driven mouse model identified CLOCK and BMAL1 as playing a key
role in regulating proliferation and differentiation pointing to a complex role of the circadian
clock in cancer progression [9]. Perturbations of the circadian clock (via experimental chronic
jet lag) in mice led to accelerated tumour growth, which could be counterbalanced by regular
timing of food access [10]. While the disruption of core-clock genes such as Per1 and Per2 has
also been associated with cancer promoting mechanisms, [11,12], their role in tumourigenesis
is still debatable because a recent study showed that Per1 or Per2 deficiency does not lead to
more tumour-prone phenotypes in mice [13]. In turn, cancer strongly influences circadian
rhythms of biological processes, such as fatty acid and cholesterol biosynthesis, and metabolic
oscillations [14,15]. Current attempts of chronobiological cancer treatment provide promising
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results, leading to a reduced toxic effect of drugs and increasing survival times of cancer
patients [16,17].
One of the processes via which the circadian clock could potentially influence tumourigen-
esis, namely by triggering malignant proliferation, might be the cell-division cycle in whose
regulation the clock is involved [18]. Several links between the circadian clock and the cell
cycle have been reported for mammalian cells [19–22]. The clock was found to unidirectionally
gate the cell cycle in mouse liver cells via a circadian expression of the cell cycle regulator
Wee1 [19], whereas in mouse fibroblasts, the circadian clock was reported to be phase-shifted
by mitosis, possibly via concentration changes of the PER-CRY complexes [20]. More recently,
the non-POU domain containing octamer binding (NONO)-PER protein complex has been
reported to couple the clock and the cell cycle by activating the rhythmic transcription of the
cell cycle checkpoint gene Ink4a [22], which encodes, as part of the Cdkn2a locus, the cyclin-
dependent kinase (CDK) inhibitor p16Ink4a [23]. p16Ink4a can be activated by the oncogene
RAS, leading to cell cycle arrest in the Gap 1 (G1) phase, a tumour-suppressive mechanism
counteracting abnormal cell proliferation [24]. A correlation between the expression level of
Per2 and the expression of Ink4a mRNA has also been reported [25], indicating that PER is a
positive regulator of Ink4a expression and might be responsible for its circadian expression. In
addition, Cdkn2a encodes for another tumour suppressor and cell cycle regulator protein,
alternate open reading frame (ARF) [26], which is mainly activated by mitogenic stimulation
through the cell cycle checkpoint protein avian myelocytomatosis viral oncogene homolog
(MYC) [27], but can also be induced via oncogenic RAS [28]. ARF interacts in a circadian
time (CT)-dependent manner with a mouse double minute 2 homolog (MDM2), a negative
regulator of the tumour suppressor gene p53 [29]. p53, in turn, directly modulates the expres-
sion of Per2 by binding to a response element in its promoter region, which is overlapping
with the E-box cis-element essential for the CLOCK/BMAL binding and the transcriptional
activation of Per2 [30]. In addition, the transcription factor E2F was described as a putative
bridging element between the circadian clock and the cell cycle [31].
Recently, we demonstrated that RAS induces a dysregulation of the mammalian circadian
clock in HaCaT keratinocyte cells [32]. We showed that the induction of RAS leads to a length-
ening of the circadian period while inhibition of the RAS/mitogen-activated protein kinases
(MAPK) pathway causes a period shortening. These findings were supported by using a math-
ematical model to analyse the rhythmic properties of the core-clock network in silico [1,32].
Other mathematical models have been developed that investigate the cell cycle-related func-
tions of the tumour suppressor genes p53 and Arf, as well as Mdm2 [33–35]. Despite the accu-
mulating experimental and in silico evidence pointing to a role of the circadian clock as a
suppressor of aberrant cell proliferation, the underlying molecular mechanisms are not yet
fully understood. Although mathematical models exist that couple elements of the cell cycle to
the components of the circadian clock [36–42], none of them include the cell cycle regulatory
genes Ink4a and Arf, nor do they include specific parameters for the investigation of the role of
oncogenic-mediated signalling via RAS.
Using mouse embryonic fibroblasts (MEFs) as a model system, we investigated the Ink4a/
Arf- and Bmal1-dependent influence of RAS on the circadian phenotype. To attain a deeper
understanding concerning the molecular interactions of the circadian clock with components
of the cell cycle, we constructed a single-cell semi-quantitative mathematical model. The
model allows for the coupling of components of the cell division cycle with the core-clock net-
work, enabling the interpretation of the RAS-mediated effect on the circadian clock phenotype
observed in Ink4a/Arf knockout MEFs as compared to their wild-type (WT) counterparts. In
particular, the model was used to attain a better understanding of the mechanism by which
INK4a and ARF might influence properties of the circadian clock. Furthermore, we performed
Ink4a/Arf: A switch-like mechanism for circadian regulation via RAS
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a comprehensive bioinformatics analysis to investigate the systemic effects of different experi-
mental perturbations at the cellular level. Expression data of a set of core-clock genes, as well
as in silico simulations, show that RAS overexpression influences the transcriptional expres-
sion and period of core-clock genes such as Bmal and Per differentially in the Ink4a/Arf+/+ and
Ink4a/Arf-/- scenarios, which points to a regulatory role of Ink4a/Arf in the RAS-mediated
effect on the circadian clock. By analysing the relevance of selected cell cycle components in
mediating the RAS-induced change on the circadian period via Ink4a/Arf in silico, we show
that the presence of the transcription factors E2F1 and p53 is necessary for simulating this phe-
notype. Genome-wide transcriptional profiling data from Ink4a/Arf-/- MEFs and their corre-
sponding WT MEFs (Ink4a/Arf+/+) are in line with the mathematical predictions showing that
Ink4a/Arf play an essential role in the RAS-mediated effect on the gene expression levels of
core-clock and cell cycle-related genes. Hence, our findings resulting from a combined
computational and experimental approach provide a deeper insight into the dynamics of the
cross-talk between oncogene-induced perturbations of the circadian system and the cell cycle
and reveal a novel role for Ink4a/Arf as an important regulator of the RAS-mediated effect on
the circadian clock phenotype.
Results
Ink4a/Arf+/+ and Ink4a/Arf-/- MEFs show different circadian phenotypes
upon oncogenic perturbation
Recently, we showed that oncogenic RAS influences properties of the circadian clock by
lengthening the circadian period in different cell types [32]. To attain a deeper mechanistic
insight on how RAS perturbs the circadian clock and on its subsequent effect on the cell cycle
and cell proliferation, we used a well-established cellular model system of MEFs. We compared
the circadian phenotypes of MEFs from WT mice (Ink4a/Arf+/+) to their littermate knock-out
MEFs (Ink4a/Arf-/-), which carry a targeted deletion of exons 2 and 3 of the tumour suppressor
gene Cdkn2a, disrupting both Ink4a and Arf [23]. We analysed the effect of RAS on the circa-
dian clock phenotype by bioluminescence recordings and the induction of senescent cell cycle
arrest by SA-ß-Gal staining. MEFs were lentivirally transduced with a Bmal1-promoter driven
luciferase construct (Bmal1:Luc) and bioluminescence was recorded for 5 days as schematically
represented in Fig 1A. The bioluminescence data shows similar clock phenotypes for Ink4a/
Arf-/- MEFs and their corresponding Ink4a/Arf+/+ littermates with average period values of
around 24 h (T = 24.7 ± 0.3 h for Ink4a/Arf+/+ MEFs and T = 24.2 ± 0.2 h for Ink4a/Arf-/-
MEFs, n = 5; mean and SEM; representative results in Fig 1B and 1C, summary of the data in
Table 1), indicating that the period of the circadian clock is not influenced by the knock-out of
Ink4a/Arf. The viability of the cells was not affected by the knockout (S1A Fig).
To specifically study the interaction of the RAS/MAPK pathway with components of the
circadian clock, oncogenic RAS (H-RAS G12V) was overexpressed in both cell types. Interest-
ingly, upon RAS overexpression, we observed a change of the circadian clock phenotype: the
RAS overexpressing Ink4a/Arf+/+ cells (T = 26.7 ± 0.7 h, n = 5; mean and SEM) show a 2 h lon-
ger period as compared to the WT condition (T = 24.7 ± 0.3 h, n = 5; mean and SEM;
p = 0.004, Student t test), whereas in the RAS-infected Ink4a/Arf-/- MEFs, a decrease of 2.5 h in
the period was observed (T = 21.7 ± 0.6 h, n = 5; mean and SEM; p = 0.0003, Student t test) as
compared to cells with unmodified RAS levels (T = 24.2 ± 0.2 h, n = 5; mean and SEM; repre-
sentative results in Fig 1B and 1C, summary of the data in Table 1). To investigate a putative
effect of RAS on core-clock components, Bmal1 was downregulated by short hairpin RNA
(shRNA) prior to the stable expression of oncogenic RAS in both Ink4a/Arf-/- MEFs and their
WT littermates. As expected, the downregulation of Bmal1 disrupted circadian rhythmicity
Ink4a/Arf: A switch-like mechanism for circadian regulation via RAS
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Fig 1. Ink4a/Arf+/+ and Ink4a/Arf-/- MEFs show different circadian phenotypes upon RAS overexpression. (A) Schematic representation of the
experimental setup to investigate the influence of RAS on the circadian phenotype via Ink4a/Arf. MEFs from Ink4a/Arf WT (Ink4a/Arf+/+) and their
Ink4a/Arf knock-out littermates (Ink4a/Arf-/-) were lentivirally transduced with a Bmal1-promoter driven luciferase construct (Bmal1:Luc). To
investigate the effect of the core-clock in this cell model system, Bmal1 was downregulated by shRNA. The effect of the oncogene RAS was
examined by overexpression of RAS. Bioluminescence was measured over five days. Shown are representative data for eight different conditions, as
indicated. (B) RAS overexpression leads to an increase of the period in Ink4a/Arf+/+ MEFs (26.9 h, dark blue) compared to the corresponding control
(24.1 h, light blue). (C) RAS overexpression shortens the period of Ink4a/Arf-/- MEFs (24.0 h, dark red) compared to the corresponding control (21.4 h,
light red). RAS overexpression disrupts the circadian clock in Bmal1 knock-down conditions in (D) Ink4a/Arf+/+ MEFs and (E) Ink4a/Arf-/- MEFs. (F)
Summary of circadian period phenotype measurements for Ink4a/Arf+/+ MEFs and Ink4a/Arf-/- MEFs with and without RAS overexpression (n = 5;
mean and SEM). (G) The cell number of Ink4a/Arf+/+ MEFs and Ink4a/Arf-/- MEFs with and without shBmal1 was monitored over five days (n = 3;
mean and SEM). Ink4a/Arf-/- MEFs proliferate faster than their corresponding Ink4a/Arf+/+ littermates, independent from Bmal1 knockdown. (H) The
cell cycle arrest phenotypes were estimated by SA-ß-Gal staining in Ink4a/Arf+/+ MEFs and their Ink4a/Arf-/- littermates with or without RAS
overexpression and Bmal1 downregulation. (I) Percentage of SA-ß-Gal staining positive cells (n = 3; mean and SEM). RAS overexpression
significantly increased the number of senescent cells in the Ink4a/Arf+/+ MEFs compared to the WT. There is no effect of Bmal1 downregulation in the
Ink4a/Arf-/- cell population. Statistical significance was determined by t test with p-values corrected for multiple testing with the Benjamini and
Hochberg method. ***p < 0.001. Numerical values are provided in S1 Data. MEF, mouse embryonic fibroblasts; ND, not defined; n.s., not significant;
RAS, rat sarcoma viral oncogene; shRNA, short hairpin RNA; T, period; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2002940.g001
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(representative results in Fig 1D and 1E, summary of the data in Table 1). Bioluminescence
data from several independent experiments (five WT mice and Ink4a/Arf-/- littermates, with
two independent transductions per condition) are summarised in Fig 1F and Table 1 and
reproduced our representative results shown in Fig 1B and 1C. Ink4a/Arf-/- MEFs proliferate
faster than the Ink4a/Arf+/+ MEFs, independent of the downregulation of Bmal1 (Fig 1G).
To investigate the effect of RAS overexpression and Bmal1 downregulation on cellular
senescence, we performed SA-ß-Gal staining using Ink4a/Arf-/- MEFS and WT littermates
(n = 3 WT mice and Ink4a/Arf-/- littermates) and tested for senescence-associated galactosi-
dase activity. While the Ink4a/Arf+/+ MEF population has a low amount of senescence cells
(7 ± 1.44%, n = 3; mean and SEM), RAS overexpression leads to a strong increase
(94.5 ± 1.15%, n = 3; mean and SEM; Fig 1H and 1I). The results are in agreement with pub-
lished data showing that RAS overexpression increases the percentage of senescent cells in WT
MEFs [24]. In comparison, the population of Ink4a/Arf-/- MEFs shows the lowest number of
senescent cells (0.83 ± 0.44%, n = 3; mean and SEM) independent of RAS overexpression
(1.5 ± 0.5%, n = 3; mean and SEM; Fig 1H and 1I). The downregulation of Bmal1 shows no sig-
nificant effect on the senescence phenotype (Fig 1H and 1I).
A mathematical model for the coupling of the circadian oscillator with the
cell division cycle
To explore the observed Ink4a/Arf-dependent effect of RAS overexpression on the clock—an
increased circadian period in WT MEFs but a decreased period in Ink4a/Arf-/- cells (Fig 1B–
1E)—we developed a novel semi-quantitative mathematical model coupling the mammalian
cell cycle and the circadian clock using ordinary differential equations (ODEs).
The model contains all elements of our previously published single-cell model of the mam-
malian circadian core-clock [1], the cell cycle elements INK4a and ARF, and a minimal selec-
tion of their respective interaction partners, which allow for the connection to the core-clock.
These include the cell cycle checkpoint regulators Myc (G1/S) and Wee1 (G2/M) and compo-
nents of two INK4a- and ARF-dependent signalling pathways: the INK4a/ retinoblastoma-
associated protein 1 (RB1)/E2F1 pathway (module 1) and the ARF/MDM2/p53 pathway
(module 2). The resulting regulatory network includes nine additional elements (MYC,
WEE1, ARF, MDM2, INK4, CDK/Cyc, p53, RB1, E2F1) and their corresponding transcrip-
tional and translational components (Fig 2A, S2 Fig). In total, the model comprises 46 vari-
ables and 170 parameters.
Table 1. The RAS-mediated effect on the circadian period is dependent on Ink4a/Arf.
Mean Values
Unmodified RAS
Period ± SEM (h)
Mean Values
RAS Overexpression
Period ± SEM (h)
Ink4a/Arf+/+ 24.7 ± 0.3 26.7 ± 0.7
Ink4a/Arf-/- 24.2 ± 0.2 21.7 ± 0.6
Ink4a/Arf+/+ shBmal1 ND ND
Ink4a/Arf-/- shBmal1 ND ND
The circadian period was estimated by bioluminescence recordings of a Bmal1:Luc reporter construct in Ink4a/Arf+/+ and Ink4a/Arf-/- MEFs. Average values
for the period ± SEM are given (n = 5 WT mice and their corresponding Ink4a/Arf-/- littermates, with 2 additional independent transductions per condition).
RAS overexpression induces a lengthening of the period in Ink4a/Arf+/+ MEFs (p < 0.005) and a shortening in Ink4a/Arf-/- MEFs (p < 0.0005). MEF, mouse
embryonic fibroblasts; ND, not defined; RAS, rat sarcoma viral oncogene; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2002940.t001
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In the model, the CLOCK/BMAL complex activates the transcription of Wee1 and represses
Myc transcription as reported in the literature [19,43,44]. The transcriptional activation of
Ink4a by the PER-NONO complex in a circadian manner [45,46] is modelled as a positive
interaction between the PER/CRY complex and Ink4a transcription. By forming a complex
with D-type CDKs CDK4 and CDK6, INK4a prevents the interaction with the cell cycle check-
point regulator Cyclin D (CycD), thereby inhibiting the subsequent phosphorylation of the
RB1, a key regulator of the E2F family of transcription factors (E2F1, E2F2, and E2F3a) [47–
51]. The dephosphorylated active form of RB1 inhibits the dissociation of the RB1/E2F com-
plex leading to the inactivation of E2F-mediated transcription of cell cycle genes. The cell
Fig 2. Circadian properties of the mathematical model reproduce the RAS-mediated effect on the clock. (A) Simplified network representation
of the mathematical model. The model consists of seven core-clock components (grey boxes) and nine cell cycle components (orange boxes).
Activating (green lines) and inhibiting (red lines) interactions known from literature and a potential transcriptional activation (reported in MotifMap) are
represented. The dashed red line from MYC to CLOCK/BMAL represents the overall interference with BMAL-mediated transcription by competitive E-
box binding. Module 1 consists of the INK4a/RB1/E2F1 pathway (green) and module 2 of the ARF/MDM2/p53 pathway (orange). (B) In silico peak
phases of clock genes from the model are consistent with experimental data. The highest mRNA expression intervals (experimental published data)
from the core-clock genes Ror (blue), Rev-Erb (red), Bmal (green), Per (purple), Cry (turquoise) and the cytoplasmic and nuclear PER/CRY protein
complexes (orange) are depicted in darker colours within the circles. Yellow dots represent the peak of expression as simulated by the model. (C)
Shown are in silico expression profiles for the five core-clock genes Bmal, Per, Cry, Ror, and Rev-Erb and for the PER/CRY protein complex. The
period was set to 23.65 h and the phase of Bmal to CT21. (D) The model reproduces experimental clock phenotypes qualitatively. In silico expression
data show that upon simulation of RAS overexpression, the Ink4a/Arf+/+ system acquires a longer period and Ink4a/Arf-/- system a shorter period
compared to the corresponding simulated WT system. RAS overexpression was simulated by decreasing the parameter ktt to 0.4 (ktt = 1 WT, ktt < 1
increase of RAS). (E) RAS overexpression increases Ink4a expression levels in silico. WT, wild-type.
https://doi.org/10.1371/journal.pbio.2002940.g002
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cycle/core-clock loop in module 1 is completed by a predicted transcriptional activation of
Bmal by E2F because E2F potentially binds to the promoter region of Bmal1 (as reported by
MotifMap, the genome-wide map of candidate regulatory motif sites for humans [52]). The
prediction of E2F as an important binding element between the clock and the cell cycle is fur-
ther supported by data from the unicellular red alga Cyanidioschyzon merolae in which time-
dependent phosphorylation of E2F promotes the G1/S transition and a mutation of the E2F
phosphorylation sites results in an uncoupling of cell cycle progression from the circadian
clock [31]. Altogether, these results point to a putative connection between E2F and the clock
which—given the existing data—can be assumed to happen via Bmal1. Module 2 contains the
ARF/MDM2/p53 pathway and represents an indirect feedback from ARF to the core-clock.
ARF is encoded by the same gene locus as INK4a and can be activated by oncogenic MYC or
oncogenic RAS [47]. Accumulated ARF associates with the p53 inhibitor MDM2 and leads to
its rapid proteasomal degradation. This decreases MDM2-mediated ubiquitination of the
tumour suppressor p53 and promotes its stabilisation, which in turn activates the transcription
of Mdm2 [53,54]. A recent study describes a p53 response element located in the promoter
region of Per2, which overlaps with the E-box cis-elements crucial for CLOCK/BMAL-medi-
ated Per2 transcription [30]. Thus, the binding of p53 strongly represses the transcription of
Per2 by competing with the CLOCK/BMAL binding to its promoter [30]. Apart from the
strong negative influence of p53 on Per2, PER2 is also known to transcriptionally modulate
p53 [55], and this regulation is thought to be positive [39]. For simplicity, we have merged the
mutual influence into one negative interaction from p53 to Per2. In addition, p53 inhibits the
phosphorylation of RB1 via the p21/CDK/CycE/RB1 pathway [56,57]. Although we cannot
exclude the possibility that other elements may also be involved in connecting the clock and
the cell cycle elements INK4a and ARF, the chosen modules represent a minimal functional
set well-supported by published data [44,58–60] that enables us to investigate the properties of
the system in silico. The model development and the complete network scheme is described in
greater detail in the supplementary information (S1 Text, S2 Fig). The resulting model is
robust to perturbations in the range of ± 10% as shown by the control coefficient analysis over
all parameters (S1 Text). The period of the model system was adjusted to 23.65 h and the phase
of Bmal mRNA expression was set to CT 21 h.
To examine whether simulations of the model are in agreement with biological phenotypes
of the clock, we compared the peak phases of the in silico mRNA expression patterns of core-
clock genes and the PER/CRY protein complexes with experimental data retrieved from the lit-
erature [1]. The peak phases for all core-clock genes are within the range of published experi-
mental peak phases of core-clock mRNAs (Fig 2B, Table 2). Furthermore, the model
successfully reproduces the correct phase relations among the core-clock components (Fig 2C).
Table 2. In silico phase differences of core-clock genes in the mathematical model.
Core-clock Elements Peak Phase (h)
Bmal 21.00
Rev-Erb 3.80
Ror 10.97
Per 11.30
Cry 12.52
PER/CRY pool 16.32
The phase of Bmal (CT 21) is taken as reference with the period length set to 23.65 h. Shown are the in silico
peak phases for all core-clock genes and the protein complex PER/CRY. CT, circadian time.
https://doi.org/10.1371/journal.pbio.2002940.t002
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The model reproduces the Ink4a/Arf-/- associated changes in the
circadian period
Data from our previous work points to a role of RAS as a regulator of the circadian clock
period [32] as was also reported by other studies [61]. With our novel mathematical model, we
investigated whether the observed RAS-induced change in the circadian clock period (Figs 1B
and 2C) can be simulated both in the Ink4a/Arf WT and in the knock-out condition (Fig 2D).
For the simulation, we adapted a method from our previous work on RAS-mediated dysregu-
lation of the circadian clock in cancer, in which a factor ktt was introduced to the activation/
inhibition rates describing CLOCK/BMAL-mediated transcription: ktt = 1 describes a normal
RAS expression level whereas ktt< 1 indicates a reduction in the transcriptional activity of
CLOCK/BMAL caused by RAS overexpression [32].
The double knock-out of Ink4a/Arf was achieved by setting the initial conditions of INK4a
and ARF mRNAs, cytoplasmic and nuclear proteins, as well as their rate of change to 0 (S1
Text, equations 1, 2, 8, 10, 14, 19 = 0). We measured the period in our model for a transient
region, defined as the mean of the time between the first four peaks (three periods) after intro-
ducing the perturbation of RAS (represented by ktt< 1) to the system. In this transient region,
there are still fluctuations of the modelled system that can represent the observed biological
noise of retrovirus-mediated RAS overexpression. More information concerning the model
analysis can be found in S1 Text.
The model predicts a slightly longer circadian period for the Ink4a/Arf-/- system (23.68 h
compared to the adjusted period of 23.65 h in the WT) when RAS is expressed at WT levels
(ktt = 1; Fig 2D), which results in a phase shift over time (S3A Fig). As expected from the
experimental data shown in Fig 1 and our previously published results [32], there is a length-
ening of the period upon RAS overexpression in Ink4a/Arf+/+ MEFs (Fig 2D). Interestingly,
the opposite effect on the period is predicted by simulations in the Ink4a/Arf-/- system. Thus,
the in silico period changes are in agreement with the experimentally measured phenotypes
in Ink4a/Arf-/- MEFs and their WT littermates (Fig 1B and 1C) and show the same tendency
of an increase/a decrease of the period length in response to RAS overexpression. The simu-
lations were not fitted to exactly reproduce the values of the experimentally measured peri-
ods, which were obtained from MEFs originating from different mice and therefore show a
certain biological variation. The simulated Ink4a/Arf-/- system shows a nonmonotonic
dependency of the period length on the strength of the RAS overexpression. With increasing
RAS, the period length first decreases, reaching its minimum for ktt = 0.7, only to increase
afterwards in response to even higher simulated levels of RAS (0.4 < ktt< 0.7; Fig 2D). After
introducing the perturbation of RAS to the system by varying the parameter ktt, there are
nonmonotonic phase shifts of Bmal expression that depend on the strength of RAS overex-
pression (S1 Text). The change of the ktt value causes Bmal oscillations to peak at different
times: The system with the strongest RAS overexpression and lowest simulated ktt value
(ktt = 0.4) peaks the earliest for the first iteration but is then superseded by the system with
ktt = 0.7 for the following iterations. The WT system always peaks last. These phase shifts are
especially prominent for the Ink4a/Arf-/- system, which represents one possible explanation
for the observed nonmonotonic period changes (Fig 2D). Yet the effect of RAS overexpres-
sion on the length of the period is also dependent on the time when the perturbation is intro-
duced to the model system (S3B Fig). Interestingly, the model predicts a longer period for an
inhibition of RAS (ktt> 1) in the Ink4a/Arf-/- system (S1 Text). We were able to confirm this
prediction experimentally by inhibiting RAS in the Ink4a/Arf-/- MEFs by using a MEK inhib-
itor that blocks the downstream chain in the RAS signalling pathway. Contrary to the short-
ened period observed when overexpressing RAS, we now observed an increase of the period
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(T = 23.76 ± 0.1 h for Ink4a/Arf-/- MEFs and T = 25.24 ± 0.1 h for Ink4a/Arf-/- -RAS MEFs;
n = 3; mean and SEM; S1C–S1E Fig). Furthermore, we simulated the overexpression of RAS
in the Ink4a/Arf+/+ condition (ktt = 0.6). The model predicts that RAS overexpression leads
to an increase of the expression level of Ink4a as compared to the normal RAS scenario (Fig
2E). This is in line with published data showing that RAS activates Ink4a, leading to cell cycle
arrest [24,27] and correlates with the RAS-induced increased number of senescent cells
shown in Fig 1I. Moreover, we downregulated RAS in the Ink4a/Arf-/- MEFs and observed a
long period phenotype, as opposed to the period change observed for RAS overexpression
(S1C–S1E Fig). Furthermore, we used an RAS-inducible construct to investigate the effects
of different levels of RAS induction. Our data indicates that both longer and shorter periods
can be observed, in a RAS-dependent manner, in agreement with the simulations from our
mathematical model (S1F–S1J Fig).
Taken together, the results demonstrate that the model reproduces important circadian
properties, which are in agreement with experimental data, and that it can be used to further
elucidate the mechanism of RAS-induced and Ink4a/Arf-dependent changes of the circadian
period.
Modular analysis of the role of the INK4a and the ARF pathway in
mediating the RAS-induced effect on the circadian clock
In order to investigate the relative influence of the INK4a/RB1/E2F1 (module 1) and ARF/
MDM2/p53 (module 2) pathways in mediating the RAS-induced effect on the core-clock in
silico, we tested whether the presence of key elements in the network and the oscillations of
both modules are necessary to reproduce the experimentally determined clock period pheno-
types of Ink4a/Arf+/+ and Ink4a/Arf-/- MEFs.
As shown in Fig 3A, module 1 represents the connection of INK4a to the clock via the
INK4a-dependent inhibition of E2F, a transcription factor that we predict to regulate the tran-
scription of Bmal in the model. Still, we cannot exclude the possibility that such a regulation
may happen via additional elements that were not investigated within the scope of this study
(S3 Text). However, additional elements would not change the validity of the conclusions
derived from the model as long as the delays in the expression values between the defined
core-clock elements remain. These delays or phase differences, which were retrieved from
published experimental data, were used as constraints in our model (S1 Text). Module 2 (Fig
3B) represents the ARF-mediated activation of the transcription factor p53, which is known to
repress the CLOCK/BMAL-mediated transcription of Per2. In both modules, the nuclear pro-
tein elements show oscillations in their simulated expression patterns according to the circa-
dian rhythm of the core-clock system (Figs 3C and 1D).
The connection of module 1 to the core-clock was disrupted by setting the concentration
of E2FN to 0 (S1 Text, equations 7, 12, 22 = 0; initial concentration of E2FN = 0), thereby
removing its predicted regulation of Bmal in the model. Ink4a/Arf knockout was modelled
as described above. Upon the disconnection of module 1, both the Ink4a/Arf+/+ and the
Ink4a/Arf-/- system acquire shorter periods when RAS is overexpressed (ktt = 0.7) as com-
pared to normal RAS conditions (ktt = 1; Fig 3E). These results are not in line with our pre-
vious simulations for the full network (Fig 2D) and the experimental observations (Fig 1A
and 1B), which show an Ink4a/Arf-dependent effect on the period upon RAS overexpres-
sion. Thus, it seems that in our modelling scenario the predicted connection between E2F
and Bmal is indeed necessary to reproduce the observed period changes. When comparing
the expression and the period length of Bmal oscillations before and after the perturbation
by RAS, it becomes evident that the knockout of module 1 results in a lower period value of
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22.86 h for both the Ink4a/Arf+/+ and the Ink4a/Arf-/- system. This results in a phase shift of
Bmal oscillations when compared to the oscillations in the WT, causing the differing effect
on the Bmal period length upon the perturbation by RAS (S1 Text). We further investigated
the relevance of the oscillations in module 1 for the RAS-mediated effect on the circadian
period. The connection between E2FN and Bmal was maintained, but the expression of E2FN
was clamped to the constitutive concentration of its mean value (S1 Text, E2FN = 5.7, equa-
tions 7, 12, 22 = 0). The constant expression of E2F leads to similar period lengths of 23.63 h
for the Ink4a/Arf+/+ and the Ink4a/Arf-/- systems (Fig 3F). In this case, RAS overexpression
causes a nonmonotonic change of the period length depending on the value of ktt, but inde-
pendent of the Ink4a/Arf status resulting in slightly shorter periods for 0.7 ktt< 1 and lon-
ger periods for 0.4 ktt< 0.7. Again, this does neither reproduce the results of the previous
simulation nor the experimental observations. Bmal oscillation profiles of both systems
shows that there is only a very small phase shift between the Ink4a/Arf+/+ and the Ink4a/
Arf-/- systems, potentially explaining why both systems react similar upon perturbation by
RAS (S1 Text). These results indicate that in the model, both the connection of the INK4a/
RB1/E2F1 module to the core-clock via E2F regulation of Bmal and the low-amplitude oscil-
lations of E2F are crucial to simulate the contrary effect of RAS overexpression on the circa-
dian period.
Next, we tested whether the connection of module 2 to the core-clock is also necessary to
reproduce the experimentally observed phenotype by setting the concentration of the compo-
nent p53N to 0 (S1 Text, equation 16 = 0). The expression profile of Bmal shows that the per-
turbation is introduced at a similar oscillation phase for both systems, which differs from that
of the WT Bmal oscillations (S1 Text). As before, both the Ink4a/Arf+/+ and the Ink4a/Arf-/-
system show a nonmonotonic change of the period dependent on the strength of the simulated
RAS overexpression: for 0.7 ktt< 1, there is a decrease in period length, followed by a slight
increase for 0.4 ktt< 0.7. This does not reproduce the experimentally observed RAS-
induced period changes indicating that the connection of the ARF/MDM2/p53 pathway to the
core-clock is crucial as well. To simulate a constitutive connection of module 2 to the core-
clock, we clamped the oscillatory expression of p53N in module 2 to its average expression
value (S1 Text, equation 16 = 0.6). Interestingly, by using a constitutive concentration of p53N,
we were able to simulate circadian phenotypes similar to the simulations of the whole network
and the experimental observations (Fig 3H). Although p53 is no longer oscillating, there is a
similar phase shift between the Ink4a/Arf+/+ and the Ink4a/Arf-/- system as in the original (S1
Text). This suggests that the oscillation of the ARF/MDM2/p53 pathway plays only a minor
Fig 3. The oscillation of the INK4a/RB1/E2F1 pathway is necessary to mediate the RAS-induced change of the
circadian phenotype. The importance of the INK4a/RB1/E2F1 pathway (module 1) (A) and the ARF/MDM2/p53 pathway
(module 2) (B) in influencing the circadian period is analysed by simulating different scenarios in silico. The simulated
expression profiles for components of module 1 (C) and module 2 (D) show oscillations with different amplitudes and peak
phases. Decoupling of module 1 from the core-clock (E) and clamping the oscillatory expression of its component E2FN to
its constitutive average value (F) lead to similar changes in the circadian period for the Ink4a/Arf+/+, and the Ink4a/Arf-/-
condition as does decoupling of module 2 from the core-clock (G). (H) The simulation of a nonrhythmic module 2 by
clamping its component p53N to its constitutive average value predicts a change in the circadian period under Ink4a/Arf+/+
conditions compared to the knock-out counterpart, indicating that the presence of both modules and the oscillation of the
INK4a/RB1/E2F1 pathway are necessary to mediate the RAS-induced change of the circadian period. Represented are the
period phenotypes in Ink4a/Arf+/+ (blue line) and Ink4a/Arf-/- (red line) systems upon RAS overexpression (ktt < 1) compared
to normal conditions (ktt = 1). The in silico expression levels of Per (I), E2f (J), and p53 N (K) are compared to 24-h time
course RT-qPCR measurements of Per2, E2f and p53 in four different conditions (Ink4a/Arf+/+, Ink4a/Arf+/++RAS, Ink4a/
Arf-/-, and Ink4a/Arf-/-+RAS; n = 2–3; mean and SD). For Per2, a harmonic regression and for E2f and p53, a polynomial
(degree 4) is fitted to the data. Numerical values are provided in S1 Data.
https://doi.org/10.1371/journal.pbio.2002940.g003
Ink4a/Arf: A switch-like mechanism for circadian regulation via RAS
PLOS Biology | https://doi.org/10.1371/journal.pbio.2002940 December 7, 2017 12 / 34
role in regulating the period in response to RAS overexpression and can instead be substituted
by a constitutive expression.
Taken together, these results indicate that upon RAS overexpression, the connections of
both the ARF/MDM2/p53 and the INK4a/RB1/E2F1 pathway to the core-clock are necessary
to produce the observed period phenotypes. The simulations from the mathematical model
predict that a circadian expression of the INK4a/RB1/E2F1 pathway is crucial for reproducing
the Ink4a/Arf-dependent change in rhythmicity in response to RAS overexpression. This again
points to dynamical effects such as phase shifting in gene expression, which are hard to identify
experimentally because even small phase shifts can cause large effects in a feedback loop.
Furthermore, we simulated the expression of representative components of the core-clock
(Per), module 1 (E2f), and module 2 (p53N) under four different conditions (Ink4a/Arf+/+,
Ink4a/Arf+/++RAS, Ink4a/Arf-/-, and Ink4a/Arf-/-+RAS) and compared them to experimental
24-h time-course measurements of Per2, E2f, and p53 under the same conditions. The knock-
out of INK4a and ARF and the overexpression of RAS (ktt = 0.6) were modelled as described
above. Both the in silico simulations and the experimental measurements show that Per is
oscillating with a circadian rhythm in all conditions (Fig 3I). As expected, there is a phase shift
in the simulated Per expression upon the knockout of Ink4a and Arf, with the knockout peak-
ing slightly later than the WT, which is in line with the phase shift observed in the simulations
of Bmal expression (S3A Fig). The same tendency can be observed in the experimental time-
course measurements of Per2. RAS overexpression reduces the amplitude of Per oscillations
both in the WT and the Ink4a/Arf-/- system (Fig 3I). E2f and p53 exhibit only low expression
changes. The simulated expression patterns of E2f show oscillations with similar amplitudes in
all four conditions while in the experimental measurements, the WT has a higher fold change
than the perturbed conditions (Fig 3J). The in silico expression of p53N shows low amplitude
oscillations in the WT conditions (both with and without RAS overexpression), which are out-
of-phase with Per oscillations (S1 Text) in agreement with a recent work that modelled the spa-
tiotemporal regulation of p53 by Per2 [39]. In the knockout condition, its expression is consti-
tutive and does not change upon overexpression of RAS (Fig 3K), which is reflected in the low
fold change observed for p53. This supports our prediction that the constitutive, but not the
oscillatory expression of the ARF/MDM2/p53 pathway is necessary to reproduce the Ink4a/
Arf-dependent effect on the circadian period upon RAS overexpression as shown in the modu-
lar analysis.
Genome-wide analysis of expression levels in perturbed MEFs shows a
dependency of the RAS-induced effect on Ink4a/Arf
To further investigate the hypothesis that Ink4a/Arf plays a crucial role in the RAS-mediated
effect on the core-clock with propagating effects on clock-regulated genes, we conducted a
genome-wide screening of gene expression upon RAS overexpression and Bmal1 downregula-
tion using microarrays of Ink4a/Arf+/+ and Ink4a/Arf-/- MEFs under the eight different condi-
tions summarised in Fig 1A. The experimental setup was validated by reverse transcription
quantitative PCR (RT-qPCR) for Bmal1, Ink4a/Arf, and the oncogene HRas (S1B Fig).
We carried out a principal component analysis (PCA) based on genome-wide expression
values (Fig 4A, S2 Fig). The eight conditions were separated into four groups along the first
three principal components. Notably, the conditions with downregulated Bmal1 are grouped
with the corresponding WT counterparts, indicating a limited effect of the Bmal1 knockdown
at the whole genome level. Upon RAS overexpression, Ink4a/Arf+/+ MEFs and Ink4a/Arf-/-
MEFs are visibly separated, reinforcing our hypothesis that Ink4a/Arf influences the RAS-
mediated effect on the system.
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To explore possible correlations between components of the circadian clock and the genes
most affected by RAS overexpression and/or knockdown of Bmal1 in Ink4a/Arf+/+ and Ink4a/
Arf-/- MEFs, we used molecular interaction data from the IntAct database [62] to create a net-
work of the two gene sets. The first gene set consists of the top 50 differentially expressed genes
whose expression levels exhibit the highest variance across the four groups determined by the
PCA (Fig 4B). The list of the topmost 50 differentially expressed genes is provided in S1 Table.
Interestingly, 32 out of the top 50 differentially expressed genes have been shown to oscillate in
the suprachiasmatic nucleus (SCN) or other peripheral tissues, such as liver, kidney, or lung,
according to the database of mammalian circadian gene expression, CircaDB [63] (S1 Table).
The second gene set is comprised of 166 clock and clock-controlled genes that constitute our
previously published network of circadian regulated genes (NCRG) [64].
For the network, we only included elements of the NCRG connected to the set of differen-
tially expressed genes via a direct interaction or via one connecting element and further
reduced the network to one connected component. The resulting network consists of three
gene/protein sets that form an undirected graph of 331 nodes, 36 of which are part of the
original differentially expressed genes and 122 are part of the NCRG (S4 and S5 Figs). The
remaining 173 nodes are connecting elements of the two gene sets. The genes from the math-
ematical model are present in all three subsets of the network (Fig 4C). Components of mod-
ules 1 and 2 can be found in the set of differentially expressed genes (Ink4a/Arf) and the set
of connecting genes (Cdk4, Cdk6, and Cyclin D1 of module 1 and p53 and Mdm2 of module
2) in addition to Myc. Five core-clock genes are part of the reduced NCRG (Bmal1, Cry1,
Cry2, Rorγ, and Rev-Erbβ). The significance of the number of direct interactions between the
differentially expressed genes and the circadian clock was tested by comparing the network
properties to those of 100 randomly generated networks based on the set of differentially
expressed genes and a set of 122 randomly chosen genes. This resulted in a considerably
lower average of 3 ± 2 interactions (mean and SD) between the set of differentially expressed
genes and the random gene sets as compared to 34 interactions with the NCRG based on
data by iRefIndex [65].
To analyse the biological significance of the network, we used consensuspath.db to deter-
mine enriched Wikipathway terms (Fig 4D and 4F). As expected, circadian rhythm-related
genes are the topmost enriched pathway. In addition, there is an overrepresentation of path-
ways related to various types of cancer such as pancreatic cancer, breast cancer, bladder cancer,
glioblastoma, and retinoblastoma. Furthermore, there are several enriched pathways that are
related to carcinogenesis, including the Wnt signalling pathway (Gsk3β, Apc), the ErbB path-
way (Erbb2, Gsk3, Myc), the TNFα pathway (Nfkb, Mapk3), the Notch signalling pathway
(Ncor1,2), and the TGF-β signalling pathway (Smad4).
Fig 4. The genome-wide effect of RAS overexpression and Bmal1 downregulation on Ink4a/Arf +/+ and Ink4a/Arf -/-
MEFs can be mirrored by genes from the mathematical model. (A) The first three principal components as determined by
genome-wide expression analysis based on microarray data of Ink4a/Arf+/+ and Ink4a/Arf-/- MEFs with different perturbations
highlighting the differences between the eight experimental conditions. The arrays cluster in four groups depending on the
presence of Ink4a/Arf and RAS overexpression. (B) Based on the four groups determined in the PCA, the top 50 differentially
expressed genes across the different experimental conditions were determined. (C) A network connecting 36 out of the
topmost 50 differentially expressed genes (orange) to the previously published NCRG (blue) by at most one connecting
element (grey) was generated using information from the IntAct database. The genes that are part of the mathematical model
are highlighted. An enrichment analysis was performed to determine the most highly represented pathways for the whole
network (D) and the set of connecting elements (F). (E) The clustering based on the expression levels of genes from the
mathematical model mimics the genome-wide clustering. (G) The expression changes of selected core-clock and cell cycle-
related genes upon perturbations by RAS and shBmal1 in Ink4a/Arf+/+ and Ink4a/Arf-/- MEFs were validated by RT-qPCR and
visualised as the log2 fold change compared to the WT MEFs. Numerical values are provided in S1 Data. MEF, mouse
embryonic fibroblasts; NCRG, network of circadian regulated genes.
https://doi.org/10.1371/journal.pbio.2002940.g004
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Additionally, several cell cycle-related pathways are among the topmost enriched terms of
the whole network including contrasting cell cycle-fate phenotypes, such as apoptosis signal-
ling, G1 to S cell cycle control, and senescence. The enrichment analysis for the set of connect-
ing elements yields similar results as the analysis for the whole network, but includes also the
MAPK signalling pathway and DNA replication among its overrepresented pathways (Fig 4F).
The high number of direct interconnections and connections via one intermediate element
between the two gene sets indicates a strong interplay between the mammalian circadian core-
clock and the genes that were differentially expressed upon RAS overexpression and/or knock-
down of Bmal1 in Ink4a/Arf+/+ and Ink4a/Arf-/- MEFs. The presence of various cell cycle-
related genes in the set of connecting components in addition to the results of the enrichment
analysis of overrepresented pathways hints at an involvement of the cell cycle in this connec-
tion. The enrichment analysis places the network connections into a potential cancer context
that involves genes affected by disturbances of the circadian system and RAS oncogenic signal-
ling, in addition to cell cycle-related genes.
Gene expression analysis of genes from the mathematical model
To specifically investigate the connection between components of the circadian clock and the
cell cycle and the effects of RAS overexpression and Bmal1 downregulation in the system, we
analysed the expression levels of 23 genes included in our mathematical model (Fig 4E, S2
Table) and validated the results for selected genes with RT-qPCR (Fig 4G). The clustering
based on the gene set mimics the overall separation on the genome-wide level as determined
by the PCA (Fig 4A) and is specific for the selected genes when compared to random sets of
the same size (p = 4.54e-07). Notably, the changes in expression of clock and cell cycle-related
genes upon RAS overexpression and downregulation of Bmal1 differ between Ink4a/Arf+/+
MEFs and their Ink4a/Arf-/- littermates.
As expected, Ink4a/Arf itself is up-regulated upon RAS overexpression as predicted by the
model (Fig 2E), which is in agreement with published data [24]. This increase is higher when
combined with the downregulation of Bmal1. When knocking out Ink4a/Arf, the connection
between the clock and cell cycle via the activation of Ink4a by the NONO-PER protein com-
plex is severed. This leads to an increase in the expression levels of several core-clock genes
such as Cry2 and Per2, while the expression level of Bmal1 does not change significantly (Fig
4G). The knockout of Ink4a/Arf differentially influences a number of cell cycle genes. Despite
being inhibited by Arf, expression of the oncogene Mdm2 decreases upon Ink4a/Arf knockout,
which in turn, leads to an increase of the expression levels of the tumour-suppressor gene p53
(Fig 4G). The consistent up-regulation of p53 in all knock-out conditions leads to a decrease in
the expression levels of the tumour suppressors p21 and Rb1, which might ultimately result in
the proliferation effect observed for the Ink4a/Arf-/- MEFs (Fig 1G).
Perturbation of the circadian clock by knockdown of the core-clock gene Bmal1 leads to an
increase in Cry2 and Per2 expression levels. However, the distinct up-regulation of Per2 levels
in Ink4a/Arf+/+ MEFs is not found in Ink4a/Arf-/- MEFs. Interestingly, the tumour suppressor
genes p53 and Rb1 are up-regulated upon Bmal1 knockdown, which points to a possible com-
pensation of the tumour-suppressor role of the circadian system.
RAS overexpression in the WT MEFs decreases the average expression levels of most core-
clock genes, such as Cry2 and Per2 with the exception of Bmal1, which shows an increased
expression (Fig 4E and 4G). This fits with our previously published data in which we showed
that overexpression of RAS decreases the activity of BMAL1 [32], which should lead to a lower
transcriptional activation of elements of the Per and Cry families. In the Ink4a/Arf-/- MEFs,
we observed a stronger RAS-induced downregulation of Cry2 and Per2, indicating that the
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influence of RAS on the circadian clock is indeed mediated by Ink4a/Arf. RAS overexpression
concurrent with Bmal1 downregulation leads to an increase in the expression levels of the
clock genes Cry2 and Per2 and the cell cycle genes Mdm2 and Rb1 in Ink4a/Arf+/+ MEFs,
whereas upon knockdown of Ink4a/Arf, the opposite effect can be observed for Cry2, Per2, and
Rb1 (Fig 4G). This shows that the effects of RAS overexpression and Bmal1 downregulation of
the expression levels of clock and cell cycle-related genes can differ between Ink4a/Arf+/+ and
Ink4a/Arf-/- MEFs, particularly when both perturbations are combined.
Predicted classification of the Ink4a/Arf+/+ and Ink4a/Arf-/- MEFs’
proliferation/senescence state is in line with experimental results
Given the strong influence of the Ink4a/Arf knockout on several clock and cell cycle genes, we
further analysed the expression across the different experimental conditions of 32 manually
curated genes associated with senescence [66–69] (S2 Table, Fig 5A).
In order to predict whether the Ink4a/Arf+/+ and Ink4a/Arf-/- MEFs exhibit normal, prolif-
erating,or senescent behaviour upon RAS overexpression and/or downregulation of Bmal1, a
machine learning analysis with a support vector machine (SVM) was performed. The SVM
algorithm creates a model based on information from a set of training conditions to predic-
tively classify the remaining conditions based on the expression of the 32 senescence-associ-
ated genes. For the training set, we selected conditions with strong cell cycle-fate phenotypes
as determined by the experimental data: Ink4a/Arf+/+ (normal), Ink4a/Arf+/++RAS (senes-
cence), and Ink4a/Arf-/- (proliferation; Fig 1G and 1I). A two-dimensional representation of
the resulting classification based on the expression of the genes Rb1 and Suv39h1, a histone
methyltransferase known to be essential for senescence [70], is shown in Fig 5B.
Ink4a/Arf+/+ shBmal1 MEFs were classified as normal, whereas senescent behaviour was
predicted for Ink4a/Arf+/+ shBmal1+RAS MEFs. This is in line with the experimental results
of the SA-β-gal staining, which showed a high percentage of senescent cells in Ink4a/Arf+/+
shBmal1+RAS MEFs, but not for Ink4a/Arf+/+ shBmal1 MEFs (Fig 1I) and similar cell growth
for Ink4a/Arf+/+ shBmal1 MEFs and their WT littermates (Fig 1G). The Ink4a/Arf-/- condi-
tions were all predicted to be proliferating. Experimentally, both Ink4a/Arf-/- and Ink4a/Arf-/-
shBmal1 MEFs have been shown to proliferate (Fig 1G). For the remaining conditions, we con-
ducted a fluorescence-activated cell sorting (FACS) analysis to determine the percentage of
cells in each cell cycle phase and compared them to those of the three training conditions
(Ink4a/Arf+/+, Ink4a/Arf+/++RAS, Ink4a/Arf-/-; Fig 5C).
FACS analysis of the WT MEFs yields a distribution of 44.1 ± 2.7% (n = 3, mean and SEM)
cells in G1 phase, 10.8 ± 2.5% in S phase, and 45.1 ± 2.7% cells in G2/M phase. The Ink4a/
Arf+/++RAS MEFs show a higher percentage of cells in G1 phase (63.6 ± 0.3%) as opposed to a
lesser number of cells in G2/M phase (25.0 ± 0.9%) as expected for senescent cells arrested in
G1 phase. In contrast, the Ink4a/Arf-/- MEFs that show a proliferating phenotype (Fig 1G)
have a larger number of cells in S phase (19.7 ± 2.5%) than the WT. Similarly, Ink4a/Arf-/-
shBmal+RAS MEFs have a higher percentage of cells in S phase (24.2 ± 10.2%) than the WT,
indicating a proliferating behaviour, as do Ink4a/Arf-/-+RAS MEFs, albeit to a smaller extent
(13.3 ± 0.8%) (Fig 5C). This shows that the expression data of the 32 senescence-associated
genes suffices to correctly predict the senescence/proliferation state of Ink4a/Arf+/+ and Ink4a/
Arf-/- MEFs upon different perturbations.
In order to compare our observations regarding the interplay between the clock and the cell
cycle in the MEFs system to human experimental models, we additionally analysed available
microarray gene expression data from different human cells (see Materials and methods).
These include the human primary fibroblast cell line IMR-90 and the human colorectal cancer
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Fig 5. Predictive classification of cell cycle-fate phenotypes for Ink4a/Arf+/+ and Ink4a/Arf-/- MEFs
based on the expression of senescence-associated genes can be validated by experimental results. (A)
A set of 32 senescence-related genes derived from the literature clusters according to the knockout of Ink4a/
Arf. (B) Two-dimensional representation of the SVM classification based on the expression of the senescence-
related genes Rb1 and Suv39h1 for the three training conditions (represented as squares) and the remaining
five predicted conditions (represented as dots). (C) FACS analysis to determine the percentage of cells in each
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(CRC) cell lines RKO, LIM1215, Caco2, HCT116, SW403, HT29, COLO205, SW480, and
SW620.
H-Ras expressing IMR-90 cells undergo oncogene-induced senescence [71] in agreement
with our observations in the MEFs system. In the published array set (GEO-GSE33613), the
downregulation of ERK2 in H-Ras expressing IMR-90 cells causes the cells to bypass senes-
cence and to proliferate instead. We analysed this dataset and found that both Bmal1 and
Ink4a/Arf were downregulated in the proliferating cells when compared to the H-Ras express-
ing IMR-90 cells as observed in the MEF cells (S6A Fig).
We further analysed available array data of human CRC cells from our own group
(GEO-GSE46549) [2] and analysed the expression of all the genes, which are represented in
our mathematical model. The comparison of the resulting heat map (S6F Fig) with the one of
Fig 4E shows large differences between the cancer cells and the primary MEF cells analysed.
Moreover, the genetic profile is very different in between the CRC cells.
In the metastatic SW620 cells, we measured an up-regulation of Ink4a/Arf and a downregu-
lation of HRas and Bmal1 as compared to the primary SW480 cells (S6B Fig). Furthermore, we
carried out cell cycle measurements by FACS for both cell lines, which show an increase in the
number of cells in S-phase and a corresponding decrease in the percentage of cells in G1-phase
for SW620 (S6E Fig). This points to an increase of proliferation associated to a reduction of
Bmal1 despite an increased level of Ink4a/Arf in these cells. We further downregulated Bmal1
in both SW480 and SW620 and analysed the subsequent effects on the cell cycle (S6C and S6D
Fig). We measured an increase of approximately 7.5% of cells in the S-phase and a similar
decrease of cells in the G1-phase for the SW480 cells (S6E Fig). No significant effect was
observed in the SW620 cells in which Bmal1 was already at low levels before its downregula-
tion (S6B Fig). It seems that the decreased expression levels of Bmal1 are associated to more
proliferative scenarios in these cell lines.
Altogether, our results reinforce the hypothesis that Ink4a/Arf—being a part of the cellular
response upon RAS overexpression—acts as a regulator for the oncogene-induced effect on
the clock phenotype and cell cycle-fate decision.
Discussion
In this study, we explore a potential mechanism via which the oncogene RAS is able to dysre-
gulate the circadian clock and the interplay of this interaction with the cell-division cycle. We
build up upon previously published data, in which we showed that the overexpression of RAS
in cancer cell lines leads to a lengthening of the clock period while its downregulation causes a
shortening [32]. RAS is also known as an elicitor of cell cycle decisions depending on the pres-
ence of the tumour suppressor genes Ink4a and Arf [23]. Moreover, recent data points to an
additional connection between the circadian clock and cell proliferation via the NONO-PER
protein complex that activates the rhythmic transcription of Ink4a [46]. Hence, we hypothesise
that the RAS-dependent dysregulation of the circadian clock might be achieved via elements
involved in the cell cycle that are interlocked with the circadian system. We explored this idea
in silico, by means of a novel mathematical model which connects the core-clock and the cell
cycle, and experimentally, using an Ink4a/Arf knock-out mouse model system.
cell cycle phase for the three training conditions (Ink4a/Arf+/+, Ink4a/Arf+/++RAS, and Ink4a/Arf-/-) and two of the
predicted conditions (Ink4a/Arf-/-+RAS and Ink4a/Arf-/- shBmal1+RAS) (n = 3; mean and SEM). The cell cycle
phases were determined by fitting a univariate cell cycle model using the Watson pragmatic algorithm. Shown
are representative examples for each condition. Numerical values are provided in S1 Data. FACS,
fluorescence-activated cell sorting; MEF, mouse embryonic fibroblasts; PI, propidium iodide.
https://doi.org/10.1371/journal.pbio.2002940.g005
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RAS perturbs the circadian clock in an Ink4a/Arf-dependent manner
We analysed the circadian clock phenotype of WT MEFs and their littermates carrying a
knockout of the tumour suppressors Ink4a and Arf, under different conditions. While the
clock period is similar for the WT and the knock-out MEFs, both cell types show an RAS-
dependent response of the clock phenotype with an opposite effect on the period length. As
expected from our previous results [32], the WT Ink4a/Arf+/+ MEFs exhibit a longer period
upon RAS overexpression. Interestingly, in the Ink4a/Arf-/- MEFs, RAS overexpression causes
a shortening of the period. We hypothesise that this differential effect might be due to a phase
shift in the expression of circadian elements that is induced by the knockout of Ink4a/Arf. The
cell cycle checkpoint and tumour suppressor gene Ink4a/Arf seems to influence the RAS-medi-
ated effect on the clock phenotype, pointing to a cross-talk between the core-clock and the cell
cycle in an oncogenic-dependent manner.
The in silico results point to the role of Ink4a/Arf as a bridging element
between the circadian clock and the cell cycle
A number of cell cycle regulators such as Myc, Wee1, and Ink4a/Arf are known to be clock-
controlled [18,19], but the complex molecular mechanisms that couple these two biological
oscillators are not entirely understood. Deeper insights into the underlying mechanisms might
be of great advantage for understanding how a disruption of our internal timing system might
induce malignant proliferation of cells in cancer.
Thus, to investigate the interplay between the circadian clock and cell cycle elements, we
developed a novel mathematical model of the mammalian core-clock that includes the tumour
suppressors Ink4a/Arf, as well as core-clock elements and cell cycle checkpoint genes, some of
which have been reported to be directly regulated by the circadian clock as described above.
The model predicts RAS-induced Ink4a/Arf-dependent changes in the length of the clock
period, as well as an RAS-induced increase of Ink4a transcription levels, which correlates with
the experimentally observed cell cycle arrest phenotype. For the model construction, we
assumed that Bmal1 transcription can be regulated by E2F as an additional coupling element
between the clock and the cell cycle based on candidate regulatory motif sites and published
data. Indeed, if we increase the strength of the E2F activation on Bmal in the model (see con-
trol coefficient analysis, S1 Text) we obtain a longer period. This is consistent with the increase
of Bmal1 transcription in the WT MEFs after RAS induction and the longer period phenotype
observed. The postulated connection between E2F activators and Bmal1 is an interesting topic
that needs further investigation.
Our in silico data show that the Ink4a/Arf-dependent changes in circadian phenotypes
upon RAS overexpression might be due to phase shifts in the oscillations of the core-clock and
subsequently also in cell cycle components. A small phase shift between the WT and the
knock-out conditions observed in the modelling simulations could also be detected in time-
course measurements of the core-clock gene Per2.
In addition, an in silico analysis that introduced RAS overexpression at different time
points showed that the time of the perturbation might be essential for the differing effects on
the period phenotype—a finding that deserves further experimental investigation and could
have consequences regarding chronotherapy research [16], but goes beyond the scope of this
study. By independently removing the ARF/MDM2/p53 pathway and the INK4a/RB1/E2F
pathway from the model, we show that the presence of both pathways is necessary to repro-
duce the experimentally observed RAS-mediated dysregulation of the circadian phenotype.
Although components of both modules oscillate in the WT simulations, the modular analysis
showed that circadian oscillations of the INK4a/RB1/E2F module are sufficient to simulate the
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observed RAS-dependent changes in the period phenotypes. This indicates that the INK4a/
RB1/E2F1 pathway is necessary for maintaining the rhythmicity of the system and that its con-
nection to the clock might be rate limiting to control cell proliferation.
Our mathematical model describes a free-running clock, which is consistent with the exper-
imental approach in which MEFs are placed under constant conditions. As a potential future
perspective, it would be interesting to investigate how our conclusions would vary when cells
are subjected to synchronising cues such as metabolic signals linked to the feeding/fasting
cycles, e.g., by integrating our clock-cell cycle model with a recent model of the mammalian
liver clock and metabolic sensors [72].
High-throughput differential gene expression analysis points to a strong
connection between the circadian clock and cell cycle elements
The tumour suppressor role of INK4a has been reported in different studies, e.g., Ink4a-defi-
cient mice develop spontaneous melanomas and are more susceptible to carcinogens than
WT mice [73]. Moreover, the tumour suppressor p53 is known to modulate Per2—a clock
gene that interacts with NONO and Ink4a—therefore, it is likely that these components are
relevant for controlling clock-dependent cell proliferation [30,39]. To get a deeper insight
into the consequences of disturbing the coupling between the cell cycle and the core-clock,
we performed a whole-genome analysis using MEFs from Ink4a/Arf-/- mice and their WT
littermates.
The genome-wide PCA of the expression data yields a separation of the Ink4a/Arf+/+ MEFs
and Ink4a/Arf-/- MEFs into four main groups. The knockout of Ink4a/Arf has the strongest
effect, followed by the perturbation by RAS. The clustering of a smaller gene set derived from
genes of the mathematical model yields a similar separation of Ink4a/Arf+/+ MEFs and Ink4a/
Arf-/- MEFs as does the genome-wide PCA. This indicates that the genome-wide differences
caused by RAS overexpression and Bmal1 downregulation are well mimicked in our interact-
ing subset of clock and cell cycle genes, and reinforces the postulated interconnection between
the core-clock and the selected cell cycle elements. To explore the putative effect of these corre-
lations on the circadian system, we determined the interconnections between the 50 topmost
differentially expressed genes and a set of circadian-regulated genes, recently published by our
group [64]. The resulting network reveals a strong interplay of the two sets via protein–protein
and protein–nucleic acid interactions, which are complemented by an additional third set of
newly retrieved connecting elements. Remarkably, components of our mathematical model
are distributed among the set of connecting elements, the topmost differentially expressed
genes and the set of circadian-regulated genes, emphasising the strong coupling between the
circadian system and cell cycle components. This synergy is further reinforced by the pathway
enrichment analysis of the whole network, which highlights several cell cycle-related terms as
well as cancer-related effector pathways.
The core-clock as a RAS-dependent enhancer of cell cycle arrest
In our MEF model system, the overexpression of the oncogene RAS leads to an increased
expression of the core-clock gene Bmal1. Even in the Bmal1 knock-down condition, the Bmal1
levels increase upon RAS overexpression, though they are still lower than in the WT, indicat-
ing a direct influence of RAS on clock components. Here, it is important to notice that Bmal1
may influence biological processes in different ways: by disrupting circadian rhythms, and/or
by influencing the expression of genes, which are direct targets of CLOCK/BMAL1 as a result
of other potential, noncircadian functions of Bmal1. Therefore, the output results of Bmal1
knock-down phenotypes must be seen in light of this wider perspective.
Ink4a/Arf: A switch-like mechanism for circadian regulation via RAS
PLOS Biology | https://doi.org/10.1371/journal.pbio.2002940 December 7, 2017 21 / 34
We further observed Ink4a/Arf-dependent changes in the expression levels of core-clock
and cell cycle-related genes: RAS overexpression in combination with shBmal1 leads to an
increase of Cry2 and Per2 when Ink4a/Arf is present, whereas it results in its downregulation
in the knock-out MEFs. The concurrent perturbations (overexpression of RAS and simulta-
neous knockdown of Bmal1) lead to an additive effect on the expression levels of genes of
the Per family. This indicates that Ink4a/Arf may be involved in regulating the gene expres-
sion of core-clock genes upon RAS overexpression, including but not limited to members of
the Per family. This correlates with changes in the expression levels of the cell cycle-related
gene Rb1 that is also up-regulated in the Ink4a/Arf+/+ shBmal1+RAS MEFs and downregu-
lated in the corresponding knock-out condition. We speculate that upon RAS-induced dys-
regulation of the core-clock, the expression level changes of the clock gene Per2 might lead
to the differential regulation of Rb1. In addition, the predicted loss of oscillations of p53
upon Ink4a/Arf knockout could account for the downregulation of Rb1 in the knock-out
MEFs and be the cause for the observed experimental variations in Rb1 gene expression
upon perturbations by RAS and shBmal1. Ultimately, this could result in abnormal cell fate
decision phenotypes, including cell-cycle arrest, which would also be in agreement with
published data [74] and points to a correlation between the core-clock gene Bmal1 and cel-
lular senescence.
Based on a curated list of senescence-related genes derived from the literature and on our
results from β-Gal-staining and growth measurements, we used a machine learning approach
to classify the cell cycle fate decision of our experimental model system upon perturbations by
RAS overexpression and dysregulation of the circadian system.
While in the Ink4a/Arf+/+ MEFs overexpression of RAS leads to oncogene-induced senes-
cence, the Ink4a/Arf-/- MEFs are classified as proliferating despite the up-regulation of the
oncogene RAS. We validated the conditions that were predicted to proliferate by cell-cycle
analysis and compared them to the WT and the senescent conditions. The downregulation of
Bmal1 shows an enhancing effect of the Ink4/Arf knockout-induced proliferation phenotype,
resulting in the highest percentage of cells in the S phase and lowest in G1 phase.
Altogether, our experimental and modelling analyses strongly point to a role for Ink4a/
Arf in mediating the clock connection to important cell cycle checkpoints and controlling its
response upon RAS oncogenic signalling. This led us to propose a model for the interplay
between the cell cycle and the circadian clock that highlights Ink4a/Arf as an important regu-
lator for the period-changing effect of RAS on the circadian clock as depicted in Fig 6. The
Ink4a/Arf locus seems to act as a switch for the effect of RAS. If the Ink4a/Arf genes are func-
tional while the system is perturbed by the oncogenic signalling, the period increases and the
cells receive a senescence signal (Fig 6A). If on the contrary, Ink4a/Arf genes are impaired,
then the period of the system decreases upon RAS perturbation, and the cells receive a prolif-
eration signal (Fig 6B). Whereas some studies have questioned the role of the clock as a
tumour suppressor [13], our data is in line with several publications including a recent work
in which enhancing circadian clock function seems to control cancer progression [75], and
points to clock dysregulation as a tumourigenesis-promoting factor. It is conceivable that the
tumourigenesis promoting/inhibiting properties of the circadian clock are context depen-
dent, and to unravel the full complexity of such interactions will require a tumour-specific
circadian analysis.
Our combined theoretical and experimental approach using a primary cell model system
interrelates high-throughput data with mathematical modelling, which together provide com-
pelling evidence for the control of both cellular oscillators, the cell division cycle, and the circa-
dian clock via the oncogene RAS. Furthermore, our data points to the existence of a fine-
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tuning system of circadian regulation via Ink4a/Arf, as a response to RAS overexpression with
severe consequences on cell fate decisions.
To see whether our results hold true for other systems as well, we analysed the expression of
Bmal1 and Ink4a/Arf in several publicly available human cells, e.g., fibroblasts and CRC cell
lines with RAS overexpression or Bmal1 downregulation. We found that RAS overexpression
leads to increased levels of Ink4a/Arf and Bmal1 in the senescent human fibroblast cell line
IMR-90 as compared to their proliferative counterparts. In the CRC cell line SW480 (derived
from the primary tumour), Bmal1 downregulation by shRNA lead to an increase of cells in S-
phase and a decrease of cells in G1-phase resembling the cell-cycle phenotype observed in the
metastasis-derived cell line SW620, in which Bmal1 was already downregulated independent
of the shRNA.
Based on our results, it seems to us that the clock is likely to act as a tumour suppressor, and
that it is of advantage for cancer cells to circumvent circadian control. One cannot stop won-
dering whether disrupted circadian timing should be included as a next potential hallmark of
cancer.
Materials and methods
Mathematical model
The semiquantitative mathematical model was derived by using the same approach as in our
previously published model of the mammalian circadian core-clock [1,32]. It contains 46 vari-
ables and 170 parameters. A detailed representation of the underlying network is shown in S2
Fig. The model comprises a set of 45 ODEs, which were implemented using Matlab R2015a
(MathWorks, Natick, MA), with ODE45, a built-in solver for non-stiff differential equations
by using a Runge-Kutta method. Both the relative error tolerance and the components of the
absolute error tolerance vector were set to 10−9. An integration step of 0.01 was used. The sys-
tem of equations was assembled by using Hill-type kinetics, mass action kinetics, and Michae-
lis-Menten kinetics. The model was parameterised following extensive literature research. The
remaining free parameters were either determined analytically or fine-tuned to fit known
Fig 6. Schematic model of the Ink4a/Arf-RAS interplay and its connections to circadian clock and cell cycle phenotypes. (A)
Overexpression of the oncogene RAS results in a lengthening of the circadian period in WT MEFs and leads to a senescent cell phenotype. (B)
Knockout of the tumour suppressor element Ink4a/Arf that connects components of both cellular oscillators, leads to a change in the RAS-induced
effect on the clock resulting in a shorter circadian period and proliferation of cells. MEF, mouse embryonic fibroblasts; RAS, rat sarcoma viral
oncogene; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2002940.g006
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core-clock phase relationships (delays) for the WT scenario. Refer to S1 Text for detailed lists
of model variables, parameters, and equations.
Lentivirus production and transduction of MEFs with the Bmal1:Luc
reporter and Bmal1 shRNA
HEK293T cells (human, kidney, ATCC Number: CRL-11268) were seeded in a 75 cm2 cell cul-
ture flask and transfected with 6 μg of psPAX packaging plasmid, 3.6 μg pMD2G envelope
plasmid, and 8.4 μg of either Bmal1-promoter-driven luciferase expression plasmid, pLKO.1
shBmal1 or nonsilencing shBmal1 control (Dharmacon Inc., Lafayette, CO) using the Cal-
Phos-mammalian transfection kit (BD Biosciences, San Jose, CA). Virus particles were har-
vested and spun at 4000 x g for 15 minutes to remove cell debris. Supernatant was passed
through a 0.45 μm filter (Sarstedt Group, Newton, NC) and used for lentiviral transduction.
WT and KO primary MEFs were isolated from embryos as previously described [76] and cul-
tured in DMEM (Gibco Laboratories, Gaithersburg, MD) containing 10% fetal calf serum
(Sigma-Aldrich, St. Louis, MO) and 1% penicillin-streptomycin (Merck Millipore, Burlington,
MA). Cells were incubated at 37˚C at 3% O2, 5% CO2. MEFs were transduced with 1.5 ml
virus filtrate plus 8 μg/μl protamine sulfate (Sigma-Alrich) in 35 mm dishes. After 1 day, the
medium was replaced with selection medium (Bmal1:Luc hygromycin 100 μg/ml, shBmal1
puromycin 10 μg/ml).
Cell culture of SW480 and SW620 cells
SW480 (human, colon, ATCC Number: CCL-228) and SW620 (human, colon, ATCC Num-
ber: CCL-227) cell lines were maintained in DMEM low glucose (Lonza Group, Basel, Switzer-
land) culture medium supplemented with 10% FBS (Life Technologies, Durham, NC), 1%
penicillin-streptomycin (Life Technologies), 2 mM Ultraglutamine (Lonza Group), and 1%
HEPES (Life Technologies). Cells were incubated at 37˚C in a humidified atmosphere with 5%
CO2.
Transduction of the CRC cell lines SW480 and SW620 with Bmal1
shRNA
A TRC lentiviral shRNA glycerol set (Dharmacon) specifically for Bmal1 was used consisting
of five individual shRNAs. The construct that gave best knock-down efficiency was determined
by gene expression analysis and used for further experiments. The transduction was carried
out as indicated above for the MEFs.
Cell culture and retroviral infection
IMR90 human diploid fibroblasts (HDFs) (human, lung, ATCC Number: CCL-186) were cul-
tivated in DMEM medium, 10% FBS, 100 U/ml penicillin-streptomycin, and transduced with
retroviral construct pBabe-Ras-BSD or pBabe-empty-BSD as control. After blasticidine selec-
tion, cells were harvested at different days and cell pellets were frozen in −80˚C for RNA
extraction.
Retrovirus production for RAS overexpression
Low-passage Phoenix cells were grown in a 10-cm petri dish to a maximal density of 70%.
20 μg MSCV-Ras-BSD plasmid (MSCV Retroviral Expression System; Clonetech Laborato-
ries, Mountain View, CA, and human hRas cDNA, Dharmacon), 15 μg helper plasmid, and
62.5 μl CaCl2 were mixed and adjusted with sterile water to 500 μl. Subsequently, 10 ml
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DMEM medium containing 25 μM chloroquine and the precipitate was added. After 12 h of
incubation, virus particles were collected. MEF cells were seeded at subconfluent density 12
h after Phoenix cell transfection. The first virus supernatant was harvested within 12 h after
transfection by aspiration and filtered through a 0.45 μm filter. The virus supernatant includ-
ing 4 μg/ml polybrene was added to the MEFs after medium change. After 12 h of incuba-
tion, the second virus supernatant was harvested as described above, supplemented with
polybrene and added to the MEFs. After spinoculation of the plates (1,500 rpm, 10 min,
32˚C), cells were grown until the next round of transduction. The third and fourth virus
supernatants were collected 12 h and 24 h later according to the same procedure. Following
the last transduction, selection medium containing 10 μg/ml blasticidin was added and cells
were selected. The protocol underlying the animal work, in compliance with Federation of
European Laboratory Animal Sciences Association’s (FELASA) guidelines, was reviewed and
approved by the Landesamt fu¨r Gesundheit und Soziales (LAGeSo), Berlin, with the identifi-
cation number G105/10.
Inhibition of Ras-MEK-ERK signalling
For RAS-inhibition assays, 2 × 105 cells were plated in 35 mm dishes and cultured overnight.
On the next day, the cells were synchronised by a single pulse of 1 μM dexamethasone (Sigma-
Aldrich) for 45 min after which an MEK inhibitor (UO126 final concentrations 10 μM; Pro-
mega Corporation, Durham, NC) was added to the culture together with 2 ml of reporter
medium containing luciferin (250 μM final concentration; PJK GmbH, Kleinblittersdorf, Ger-
many). Luciferase activity was monitored for five days using a photomultiplier tube (PMT)-
based device (LumiCycle; Actimetrics Inc., Evanston, IL). The Chronostar software was used
for data analysis [77].
Inducible Ras overexpression
For RAS-overexpression assays, 2 × 105 cells were transduced with a construct encoding
H-RASG12V as described previously [41] were plated in 35 mm dishes and cultured in medium
containing 4-hydroxytamoxifen (4OHT) (Sigma-Aldrich) was used at 1 nM, 10 nM, and 100
nM for 5 days. On the sixth day, cells were synchronised by a single pulse of 1 μM dexametha-
sone (Sigma-Aldrich) for 45 min. Individual dishes were washed with phosphate-buffered
saline, and 2 ml of reporter medium containing luciferin (250 μM final concentration, PJK
GmbH) was added per dish, after which 4OHT was added again to the culture in the concen-
trations as previously described. Ethanol was used as a solvent control.
Synchronisation of MEFs and monitoring of the Bmal1 promoter activity
Ink4a/Arf+/+ and Ink4a/Arf-/- MEFs (from five WT mice and KO littermates) harbouring the
Bmal1-promoter-driven luciferase reporter construct (two independent transductions per
condition) were synchronised with dexamethasone (1 μM final concentration, Sigma-Aldrich)
for 45 min. Individual dishes were washed with phosphate-buffered saline, and 2 ml of
reporter medium containing luciferin (250 μM final concentration, PJK GmbH) was added
per dish. Luciferase activity was monitored for five days using a PMT-based device (Lumi-
Cycle, Actimetrics). The Chronostar software was used for data analysis [77].
SA-β-galactosidase staining
MEF cells were seeded in 6- or 12-well plates containing 5 mm round glass cover-slips and
incubated under standard conditions overnight to let the cells attach. Afterwards, medium
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was removed and cells were fixed in freshly prepared fixation solution (0.25% Glutaralde-
hyde, 2% Paraformaldehyde in PBS containing 1 mM MgCl2) at room temperature. After 15
min incubation, fixation solution was removed and cells were washed twice in phosphate-
buffered saline. Staining solution was added and plates were transferred and incubated in a
humidified atmosphere at 37˚C for 16 h. Cells were gently washed with PBS and mounted
afterwards. On each slide 200 cells were analysed, and the blue-stained cells were counted as
positive.
Chromatin immunoprecipitation and quantitative PCR (ChIP-qPCR)
analyses
ChIP-qPCR assays were performed using the iDeal ChIP-seq kit (Diagenode s.a., Liège, Bel-
gium) with a primer pair specific for the promoters of Bmal1. Primer sequences are available
upon request.
RNA extraction and gene expression analysis by RT-qPCR
Total RNA from MEFs was isolated with the RNeasy Mini kit (Qiagen, Hilden, Germany)
following the manufacturer instructions. Microarray hybridisation was carried out by the
Labor fu¨r funktionelle Genomforschung (LFGC, Charite´—Universita¨tsmedizin Berlin)
using Affymetrix Mouse Exon 1.0 ST arrays. For RT-qPCR analysis, the extracted RNA was
reverse transcribed into cDNA by using random hexamers (Eurofins MWG Operon, Hunts-
ville, AL) and Reverse Transcriptase (Life Technologies). RT-qPCR was performed using
mouse QuantiTect Primer assays (Qiagen) and SYBR Green fluorescence assays (Life Tech-
nologies). For the detection of human Ras expression, a human Quantitect Primer assay
(Qiagen) was used. RNA was analysed with a real-time PCR System (Applied Biosystems,
Foster City, CA). For selected genes, we harvested MEFs around one circadian cycle in
three-h intervals and performed a time-course RT-qPCR analysis. Gene expression levels
were normalised to mouse Gapdh mRNA (Eurofins MWG Operon, fwd: ACGGGAAGCT
CACTGGCATGGCCTT rev: CATGAGGTCCACCACCCTGTTGCTG). The log2-fold
change in expression of the target genes in the different conditions (Ink4a/Arf+/+/Ink4a/
Arf-/- MEFs with and without Ras and Ink4a/Arf+/+/Ink4a/Arf-/- MEFs with and without
shBmal1) in relation to the control (Ink4a/Arf+/+) was calculated as ΔΔC. For the time-
course analysis, the log2-fold change was calculated in comparison to the expression at 0 h.
The cosine function fitted to the time-course data was calculated with the R package Harmo-
nicRegression [78].
For the human cell lines SW480, SW620, and IMR-90 RT-qPCR was performed by using
human QuantiTect Primer assays (Qiagen) and SYBR Green (Bio-Rad Laboratories, Hercules,
CA) in 96-well plates. Tbp or Gapdh were used as housekeeping genes. The qPCR reaction
and the subsequent melting curve were performed using a real-time PCR Detection System
(Bio-Rad). C values were determined by using the regression method. The log2-fold change in
gene expression in relation to the respective control was calculated as ΔΔC.
FACS analysis
MEF cells (from three mice and KO littermates), SW480, and SW620 cells used for cell cycle
evaluations were labelled with 10 μM of BrdU/1x106 cells for 60 min, then collected and
washed with 1 x PBS and fixed with ice-cold 80% ethanol. After DNA denaturation with 2 N
HCl/Triton x-100, samples were neutralised with 0.1 M Na2B4O7, washed with PBS, and
stained with 3 μL of anti-BrdU-FITC (BD Biosciences Clone B44), in a 1 x PBS solution con-
taining 0.5% Tween20, 1% BSA, and 10 mg/mL of RNase (AppliChem GmbH, Darmstadt,
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Germany) for 1 h at room temperature. Supernatant was removed, cells resuspended in 200 μL
of 1xPBS containing 5 μg/mL of PI (Sigma-Aldrich), and read in FACSCabilur (Becton Dick-
inson, Franklin Lakes, NJ). The cells of interest were gated based on forward scatter/side scat-
ter (FSC versus SSC) values (S4 Text). The cell cycle analysis was conducted by fitting a
univariate cell cycle model to the previously gated population using the Watson pragmatic
algorithm [79] as implemented in FlowJo v10.2 (FlowJo, LLC, Ashland, OR).
Microarray analysis
The microarray data was analysed in R version 3.2.3 using the oligo package [80]. Expression
levels of genes were calculated using the Robust Multi-Array Average (RMA) preprocessing
procedure [81]. Mouse exon arrays were annotated by using the moex10sttranscriptcluster.db
package. Heatmaps of clustered gene expression were generated by using the ComplexHeat-
map package [82]. Hierarchical clustering with Pearson correlation was used to build the heat-
maps. The R packages arrayQualityMetrics [83], affycoretools, and ReportingTools [84] were
used for quality control and statistical testing of the arrays (S2 Text).
The microarray dataset has been deposited in the ArrayExpress database at EMBL-EBI
(www.ebi.ac.uk/arrayexpress) under the accession number E-MTAB-5943. The calculation of
the principal components was performed with built-in functions of R and visualised with the
scatterplot3d package. Differentially expressed genes were determined with the limma package
[85]. Analysis of the statistical significance of the resulting clusters was performed with the Sig-
Clust package [86].
We also tested the expression of our genes of interest (Ink4a/Arf, Bmal1, HRas) in publicly
available microarrays of different human cell lines: human primary fibroblasts (IMR-90) with
stably expressing H-RasV12 and shRNA against ERK2 or a nontargeting shRNA (GEO-
GSE33613), and the CRC cell lines RKO, LIM1215, Caco2, HCT116, SW403, HT29,
COLO205, SW480, and SW620 (GEO-GSE46549).
Network generation and analysis
Gene and protein regulatory networks were generated using Cytoscape version 3.4 [87]. Addi-
tional information for the network was retrieved from the IntAct database of the EBI-EMBL
[62] by mapping the NCBI Gene ID to Ensembl Gene IDs and Uniprot IDs. Pathway enrich-
ment was performed with consensuspath.db. Random network analysis was performed with
the iRefR package for R and iRefIndex version 14.0 with the IntAct database.
SVM classification
In order to predict the senescence/proliferation behaviour of the different experimental condi-
tions, a machine learning analysis was performed on a subset of the microarray data with the
SVM algorithm of the e1071 R package. The dataset consists of 32 manually curated genes
associated with senescence [66–69]. The conditions used as the training set were Ink4a/Arf+/+,
Ink4a/Arf+/++RAS, and Ink4a/Arf-/-+RAS.
Supporting information
S1 Fig. Effects of shBmal1 and RAS inhibition/induction in MEF cells. (A) The cell viability
of wild type MEFs and Ink4a/Arf-/- MEFs with and without shBmal1 was monitored over five
days (n = 3; mean and SEM). (B) The knockdown of Bmal1, the knockout of Ink4a/Arf and the
overexpression of RAS were validated by RT-qPCR. The expression level of Bmal1 decreases to
about 30% upon its downregulation with shRNA, as compared to the wild type value. (C)
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Summary of circadian period phenotype measurements for Ink4a/Arf-/- MEFs with and with-
out RAS inhibition (n = 3; mean and SEM). (D,E) RAS inhibition (Ink4a/Arf-/--RAS) prolongs
the period of Ink4a/Arf-/- MEFs (25 h, orange) compared to the corresponding control (23.2 h,
red). (F) Summary of circadian period phenotype measurements for Ink4a/Arf-/- MEFs with
and without induction of RAS with 4OHT (n = 2; mean and SEM). (G-J) RAS induction
(Ink4a/Arf-/-+RAS, 4OHT = 1 nM, 10 nM, 100 nM) causes different effects on the period of
Ink4a/Arf-/- MEFs compared to the corresponding control (26.1 h, red). Numerical values are
provided in S1 Data.
(PDF)
S2 Fig. Detailed diagram of the mathematical model. The network comprises two compart-
ments, the nucleus and the cytoplasm. There are 46 variables in total. For most gene entities,
the mRNA (blue), cytoplasmic protein (purple) and nuclear protein (yellow) are distinguished.
The transcriptional activation, phosphorylation/dephosphorylation processes are represented
in green lines, the transcriptional repressions are represented by red lines. Translation and
nuclear importation/exportation processes are represented by black lines while complex for-
mation/dissociation processes are represented using brown lines.
(PDF)
S3 Fig. In silico clock phenotype variation in an Ink4a/Arf-RAS-dependent manner. (A) In
silico simulations show that the knockout system has a phase shift in the expression patterns of
core-clock genes (represented by Bmal). (B) The time point of introducing RAS overexpres-
sion to the system influences the resulting period changes in the simulated wild type and the
knockout systems.
(PDF)
S4 Fig. Network of differentially expressed genes and clock-related genes. Network con-
necting 36 of the top 50 differentially expressed genes across the eight experimental conditions
(red) with a set of 122 clock-related genes (blue) connected by 173 connecting elements (grey).
Genes from the mathematical model are framed with a green line.
(PDF)
S5 Fig. Cytoscape network of differentially expressed genes and clock-related genes. Cytos-
cape file of the network connecting 36 of the top 50 differentially expressed genes across the
eight experimental conditions (red) with a set of 122 clock-related genes (blue) connected by
173 connecting elements (grey). Genes from the mathematical model are framed with a green
line.
(CYS)
S6 Fig. Interplay between the circadian clock and the cell cycle in human CRC cell lines.
(A) The proliferative phenotype in IMR-90 cells (shERK2+RAS) vs its senescence counterpart
(shCTRL+RAS) shows similar fold changes in Bmal1 and Ink4a/Arf expression as compared to
the MEFs system. Analysis from published microarray data (GEO—GSE33613). (B) A down-
regulation of Bmal1 expression is observed in the metastatic CRC cell line (SW620) vs the pri-
mary tumour cell line (SW480). Analysis from published microarray data (GEO—GSE46549).
(C,D) Downregulation of Bmal1 leads to an increase of the tumour suppressor Ink4a/Arf in
SW480 (RT-qPCR data: n = 3; mean and SEM). (E) FACS analysis to determine the percentage
of cells in each cell cycle phase for the CRC cell lines SW480 and SW620 (control and shBmal1,
n = 3; mean and SEM). The cell cycle phases were determined by fitting a univariate cell cycle
model using the Watson pragmatic algorithm. (F) Heatmap for the genes of the mathematical
model in human CRC cell lines. Analysis from published microarray data (GEO—GSE46549).
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Numerical values are provided in S1 Data.
(PDF)
S1 Table. Top 50 differentially expressed genes across all eight conditions. The 50 topmost
differentially expressed genes across the eight samples were determined with the R package
limma based on the four clusters as determined by the PCA (p-value < 0.005). 32 of the genes
were reported to be oscillating in CircaDB.
(XLSX)
S2 Table. Expression values for genes from the mathematical model and for a curated list
of senescence-related genes for all eight conditions. Log2-normalised expression values
under all eight experimental conditions for 23 genes included in the mathematical model and
for a curated list of 32 senescence-related genes based on literature research.
(XLSX)
S1 Text. Description of the mathematical model. Detailed description of the mathematical
model’s development, variables, parameters and equations. Additional model analysis and
control coefficient analysis of the mathematical model parameters.
(PDF)
S2 Text. Microarray quality control. Microarray data were subjected to standard statistical
tests to assess their quality.
(PDF)
S3 Text. Potential link between Clock/Bmal and E2f.
(PDF)
S4 Text. Gating strategies for the FACS analysis. Description of the gating strategies applied
for the cell cycle analysis of the MEF cells and the SW480 and SW620 cells.
(PDF)
S1 Data. Data overview for numerical values in figures.
(XLSX)
Acknowledgments
We thank Nadine Burbach, Katja Reimers, and Claudia Hayford from the group of C. Schmitt
for technical help regarding the work with the MEFs. We thank Ute Ungethu¨m from the
LFGC (Charite´—Universita¨tsmedizin Berlin) for technical support regarding the microarrays
work.
Author Contributions
Conceptualization: Clemens A. Schmitt, Angela Relo´gio.
Formal analysis: Rukeia El-Athman, Nikolai N. Genov, Angela Relo´gio.
Funding acquisition: Achim Kramer, Clemens A. Schmitt, Angela Relo´gio.
Investigation: Rukeia El-Athman, Nikolai N. Genov, Jeannine Mazuch, Angela Relo´gio.
Methodology: Rukeia El-Athman, Nikolai N. Genov, Jeannine Mazuch, Kaiyang Zhang, Yong
Yu, Luise Fuhr, Mo´nica Abreu, Yin Li, Thomas Wallach.
Project administration: Angela Relo´gio.
Resources: Achim Kramer, Clemens A. Schmitt, Angela Relo´gio.
Ink4a/Arf: A switch-like mechanism for circadian regulation via RAS
PLOS Biology | https://doi.org/10.1371/journal.pbio.2002940 December 7, 2017 29 / 34
Supervision: Angela Relo´gio.
Validation: Jeannine Mazuch, Yong Yu, Luise Fuhr, Mo´nica Abreu, Yin Li, Thomas Wallach.
Visualization: Rukeia El-Athman, Nikolai N. Genov, Jeannine Mazuch, Angela Relo´gio.
Writing – original draft: Rukeia El-Athman, Jeannine Mazuch, Angela Relo´gio.
Writing – review & editing: Rukeia El-Athman, Nikolai N. Genov, Jeannine Mazuch, Kaiyang
Zhang, Yong Yu, Luise Fuhr, Mo´nica Abreu, Yin Li, Thomas Wallach, Achim Kramer,
Clemens A. Schmitt, Angela Relo´gio.
References
1. Relogio A, Westermark PO, Wallach T, Schellenberg K, Kramer A, Herzel H. Tuning the mammalian cir-
cadian clock: robust synergy of two loops. PLoS Comput Biol. 2011; 7(12):e1002309. https://doi.org/10.
1371/journal.pcbi.1002309 PMID: 22194677
2. Fuhr L, Abreu M, Pett P, Relo´gio A. Circadian systems biology: When time matters. Computational and
structural biotechnology journal. 2015; 13:417–26. https://doi.org/10.1016/j.csbj.2015.07.001 PMID:
26288701
3. Sukumaran S, Almon RR, DuBois DC, Jusko WJ. Circadian rhythms in gene expression: Relationship
to physiology, disease, drug disposition and drug action. Adv Drug Deliv Rev. 2010; 62(9–10):904–17.
https://doi.org/10.1016/j.addr.2010.05.009 PMID: 20542067
4. Sahar S, Sassone-Corsi P. Metabolism and cancer: the circadian clock connection. Nat Rev Cancer.
2009; 9(12):886–96. Epub 2009/11/26. https://doi.org/10.1038/nrc2747 PMID: 19935677.
5. Sancar A, Lindsey-Boltz LA, Gaddameedhi S, Selby CP, Ye R, Chiou Y-Y, et al. Circadian clock, can-
cer, and chemotherapy. Biochemistry. 2014; 54(2):110–23. https://doi.org/10.1021/bi5007354 PMID:
25302769
6. Tynes T, Hannevik M, Andersen A, Vistnes AI, Haldorsen T. Incidence of breast cancer in Norwegian
female radio and telegraph operators. Cancer Causes Control. 1996; 7(2):197–204. PMID: 8740732.
7. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Night-shift work and
risk of colorectal cancer in the nurses’ health study. J Natl Cancer Inst. 2003; 95(11):825–8. PMID:
12783938.
8. Travis RC, Balkwill A, Fensom GK, Appleby PN, Reeves GK, Wang X-S, et al. Night shift work and
breast cancer incidence: three prospective studies and meta-analysis of published studies. Journal of
the National Cancer Institute. 2016; 108(12):djw169.
9. Puram RV, Kowalczyk MS, de Boer CG, Schneider RK, Miller PG, McConkey M, et al. Core circadian
clock genes regulate leukemia stem cells in AML. Cell. 2016; 165(2):303–16. https://doi.org/10.1016/j.
cell.2016.03.015 PMID: 27058663
10. Filipski E, Levi F. Circadian disruption in experimental cancer processes. Integr Cancer Ther. 2009; 8
(4):298–302. https://doi.org/10.1177/1534735409352085 PMID: 20042408.
11. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler HP. The circadian gene per1 plays an important
role in cell growth and DNA damage control in human cancer cells. Mol Cell. 2006; 22(3):375–82. Epub
2006/05/09. https://doi.org/10.1016/j.molcel.2006.03.038 PMID: 16678109.
12. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG. Deregulated expression of the PER1, PER2
and PER3 genes in breast cancers. Carcinogenesis. 2005; 26(7):1241–6. Epub 2005/03/26. https://doi.
org/10.1093/carcin/bgi075 PMID: 15790588.
13. Antoch MP, Toshkov I, Kuropatwinski KK, Jackson M. Deficiency in PER proteins has no effect on the
rate of spontaneous and radiation-induced carcinogenesis. Cell Cycle. 2013; 12(23):3673–80. https://
doi.org/10.4161/cc.26614 PMID: 24091726
14. Masri S, Papagiannakopoulos T, Kinouchi K, Liu Y, Cervantes M, Baldi P, et al. Lung Adenocarcinoma
Distally Rewires Hepatic Circadian Homeostasis. Cell. 2016; 165(4):896–909. https://doi.org/10.1016/j.
cell.2016.04.039 PMID: 27153497.
15. Altman BJ, Hsieh AL, Sengupta A, Krishnanaiah SY, Stine ZE, Walton ZE, et al. MYC disrupts the circa-
dian clock and metabolism in cancer cells. Cell metabolism. 2015; 22(6):1009–19. https://doi.org/10.
1016/j.cmet.2015.09.003 PMID: 26387865
16. Dallmann R, Okyar A, Levi F. Dosing-Time Makes the Poison: Circadian Regulation and Pharmacother-
apy. Trends Mol Med. 2016; 22(5):430–45. https://doi.org/10.1016/j.molmed.2016.03.004 PMID:
27066876.
Ink4a/Arf: A switch-like mechanism for circadian regulation via RAS
PLOS Biology | https://doi.org/10.1371/journal.pbio.2002940 December 7, 2017 30 / 34
17. Ballesta A, Innominato PF, Dallmann R, Rand DA, Le´vi FA. Systems Chronotherapeutics. Pharmaco-
logical Reviews. 2017; 69(2):161–99. https://doi.org/10.1124/pr.116.013441 PMID: 28351863
18. Masri S, Cervantes M, Sassone-Corsi P. The circadian clock and cell cycle: interconnected biological
circuits. Current opinion in cell biology. 2013; 25(6):730–4. https://doi.org/10.1016/j.ceb.2013.07.013
PMID: 23969329
19. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian
clock for timing of cell division in vivo. Science. 2003; 302(5643):255–9. https://doi.org/10.1126/
science.1086271 PMID: 12934012
20. Nagoshi E, Saini C, Bauer C, Laroche T, Naef F, Schibler U. Circadian gene expression in individual
fibroblasts: cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell. 2004;
119(5):693–705. https://doi.org/10.1016/j.cell.2004.11.015 PMID: 15550250
21. Zhang EE, Liu AC, Hirota T, Miraglia LJ, Welch G, Pongsawakul PY, et al. A genome-wide RNAi screen
for modifiers of the circadian clock in human cells. Cell. 2009; 139(1):199–210. https://doi.org/10.1016/j.
cell.2009.08.031 PMID: 19765810
22. Kowalska E, Ripperger JA, Hoegger DC, Bruegger P, Buch T, Birchler T, et al. NONO couples the circa-
dian clock to the cell cycle. Proceedings of the National Academy of Sciences. 2013; 110(5):1592–9.
23. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA. Role of the INK4a locus in tumor
suppression and cell mortality. Cell. 1996; 85(1):27–37. PMID: 8620534.
24. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senes-
cence associated with accumulation of p53 and p16INK4a. Cell. 1997; 88(5):593–602. PMID: 9054499.
25. Storcelova M, Vician M, Reis R, Zeman M, Herichova I. Expression of cell cycle regulatory factors hus1,
gadd45a, rb1, cdkn2a and mre11a correlates with expression of clock gene per2 in human colorectal
carcinoma tissue. Mol Biol Rep. 2013; 40(11):6351–61. Epub 2013/09/26. https://doi.org/10.1007/
s11033-013-2749-2 PMID: 24062075.
26. Ivanchuk SM, Mondal S, Dirks PB, Rutka JT. The INK4A/ARF locus: role in cell cycle control and apo-
ptosis and implications for glioma growth. Journal of neuro-oncology. 2001; 51(3):219–29. PMID:
11407594
27. Schmitt CA. Senescence, apoptosis and therapy—cutting the lifelines of cancer. Nat Rev Cancer.
2003; 3(4):286–95. https://doi.org/10.1038/nrc1044 PMID: 12671667.
28. Lin AW, Lowe SW. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transfor-
mation. Proceedings of the National Academy of Sciences. 2001; 98(9):5025–30.
29. Horiguchi M, Koyanagi S, Hamdan AM, Kakimoto K, Matsunaga N, Yamashita C, et al. Rhythmic con-
trol of the ARF-MDM2 pathway by ATF4 underlies circadian accumulation of p53 in malignant cells.
Cancer research. 2013; 73(8):2639–49. https://doi.org/10.1158/0008-5472.CAN-12-2492 PMID:
23580573
30. Miki T, Matsumoto T, Zhao Z, Lee CC. p53 regulates Period2 expression and the circadian clock. Nat
Commun. 2013; 4:2444. Epub 2013/09/21. https://doi.org/10.1038/ncomms3444 PMID: 24051492
31. Miyagishima S-y, Fujiwara T, Sumiya N, Hirooka S, Nakano A, Kabeya Y, et al. Translation-indepen-
dent circadian control of the cell cycle in a unicellular photosynthetic eukaryote. Nature communica-
tions. 2014; 5:3807. https://doi.org/10.1038/ncomms4807 PMID: 24806410
32. Relogio A, Thomas P, Medina-Perez P, Reischl S, Bervoets S, Gloc E, et al. Ras-mediated deregulation
of the circadian clock in cancer. PLoS Genet. 2014; 10(5):e1004338. Epub 2014/05/31. https://doi.org/
10.1371/journal.pgen.1004338 PMID: 24875049
33. Lev Bar-Or R, Maya R, Segel LA, Alon U, Levine AJ, Oren M. Generation of oscillations by the p53-
Mdm2 feedback loop: a theoretical and experimental study. Proceedings of the National Academy of
Sciences of the United States of America. 2000; 97(21):11250–5. https://doi.org/10.1073/pnas.
210171597 PMID: 11016968
34. Proctor CJ, Gray DA. Explaining oscillations and variability in the p53-Mdm2 system. BMC systems biol-
ogy. 2008; 2:75. https://doi.org/10.1186/1752-0509-2-75 PMID: 18706112
35. Leenders GB, Tuszynski JA. Stochastic and Deterministic Models of Cellular p53 Regulation. Frontiers
in oncology. 2013; 3:64. https://doi.org/10.3389/fonc.2013.00064 PMID: 23565502
36. Altinok A, Le´vi F, Goldbeter A. A cell cycle automaton model for probing circadian patterns of anticancer
drug delivery. Advanced drug delivery reviews. 2007; 59(9):1036–53.
37. Ge´rard C, Goldbeter A. Entrainment of the mammalian cell cycle by the circadian clock: modeling two
coupled cellular rhythms. PLoS Comput Biol. 2012; 8(5):e1002516. https://doi.org/10.1371/journal.pcbi.
1002516 PMID: 22693436
38. Za´mborszky J, Hong CI, Nagy AC. Computational analysis of mammalian cell division gated by a circa-
dian clock: quantized cell cycles and cell size control. Journal of biological rhythms. 2007; 22(6):542–
53. https://doi.org/10.1177/0748730407307225 PMID: 18057329
Ink4a/Arf: A switch-like mechanism for circadian regulation via RAS
PLOS Biology | https://doi.org/10.1371/journal.pbio.2002940 December 7, 2017 31 / 34
39. Gotoh T, Kim JK, Liu J, Vila-Caballer M, Stauffer PE, Tyson JJ, et al. Model-driven experimental
approach reveals the complex regulatory distribution of p53 by the circadian factor Period 2. Proceed-
ings of the National Academy of Sciences. 2016; 113(47):13516–21.
40. Matsu-ura T, Dovzhenok A, Aihara E, Rood J, Le H, Ren Y, et al. Intercellular Coupling of the Cell Cycle
and Circadian Clock in Adult Stem Cell Culture. Molecular Cell. 2016; 64(5):900–12. https://doi.org/10.
1016/j.molcel.2016.10.015 PMID: 27867006
41. Bieler J, Cannavo R, Gustafson K, Gobet C, Gatfield D, Naef F. Robust synchronization of coupled cir-
cadian and cell cycle oscillators in single mammalian cells. Molecular systems biology. 2014; 10(7):739.
42. Feillet C, Krusche P, Tamanini F, Janssens RC, Downey MJ, Martin P, et al. Phase locking and multiple
oscillating attractors for the coupled mammalian clock and cell cycle. Proceedings of the National Acad-
emy of Sciences. 2014; 111(27):9828–33.
43. Fu L, Pelicano H, Liu J, Huang P, Lee CC. The circadian gene Period2 plays an important role in tumor
suppression and DNA damage response in vivo. cell. 2002; 111(1):41–50. PMID: 12372299
44. Sahar S, Sassone-Corsi P. Metabolism and cancer: the circadian clock connection. Nature Reviews
Cancer. 2009; 9(12):886–96. https://doi.org/10.1038/nrc2747 PMID: 19935677
45. Kowalska D, Krajnik B, Olejnik M, Twardowska M, Czechowski N, Hofmann E, et al. Metal-enhanced
fluorescence of chlorophylls in light-harvesting complexes coupled to silver nanowires. TheScientific-
WorldJournal. 2013; 2013:670412. https://doi.org/10.1155/2013/670412 PMID: 23533354
46. Kowalska E, Ripperger JA, Hoegger DC, Bruegger P, Buch T, Birchler T, et al. NONO couples the circa-
dian clock to the cell cycle. Proceedings of the National Academy of Sciences of the United States of
America. 2013; 110(5):1592–9. https://doi.org/10.1073/pnas.1213317110 PMID: 23267082
47. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, et al. Myc signaling via the ARF
tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 1998; 12
(15):2424–33. PMID: 9694806
48. Grandinetti KB, David G. Sin3B: an essential regulator of chromatin modifications at E2F target promot-
ers during cell cycle withdrawal. Cell Cycle. 2008; 7(11):1550–4. https://doi.org/10.4161/cc.7.11.6052
PMID: 18469515.
49. Rayman JB, Takahashi Y, Indjeian VB, Dannenberg JH, Catchpole S, Watson RJ, et al. E2F mediates
cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor
complex. Genes Dev. 2002; 16(8):933–47. https://doi.org/10.1101/gad.969202 PMID: 11959842
50. Nevins JR. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science. 1992;
258(5081):424–9. PMID: 1411535.
51. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995; 81(3):323–30. PMID:
7736585.
52. Xie X, Rigor P, Baldi P. MotifMap: a human genome-wide map of candidate regulatory motif sites. Bioin-
formatics. 2009; 25(2):167–74. Epub 2008/11/20. https://doi.org/10.1093/bioinformatics/btn605 PMID:
19017655
53. Moll UM, Petrenko O. The MDM2-p53 interaction. Mol Cancer Res. 2003; 1(14):1001–8. Epub 2004/01/
07. PMID: 14707283.
54. Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D. Nucleolar Arf sequesters Mdm2 and activates
p53. Nature cell biology. 1999; 1(1):20–6. https://doi.org/10.1038/8991 PMID: 10559859.
55. Gotoh T, Vila-Caballer M, Santos CS, Liu J, Yang J, Finkielstein CV. The circadian factor Period 2 mod-
ulates p53 stability and transcriptional activity in unstressed cells. Molecular biology of the cell. 2014; 25
(19):3081–93. https://doi.org/10.1091/mbc.E14-05-0993 PMID: 25103245
56. Robles SJ, Adami GR. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and
the premature senescence of normal fibroblasts. Oncogene. 1998; 16(9):1113–23. Epub 1998/04/07.
https://doi.org/10.1038/sj.onc.1201862 PMID: 9528853.
57. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression.
Genes Dev. 1999; 13(12):1501–12. Epub 1999/07/01. PMID: 10385618.
58. Fu L, Kettner NM. The circadian clock in cancer development and therapy. Progress in molecular biol-
ogy and translational science. 2013; 119:221. https://doi.org/10.1016/B978-0-12-396971-2.00009-9
PMID: 23899600
59. Kelleher FC, Rao A, Maguire A. Circadian molecular clocks and cancer. Cancer letters. 2014; 342(1):9–
18. https://doi.org/10.1016/j.canlet.2013.09.040 PMID: 24099911
60. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nature reviews Cancer. 2003; 3
(5):350. https://doi.org/10.1038/nrc1072 PMID: 12724733
Ink4a/Arf: A switch-like mechanism for circadian regulation via RAS
PLOS Biology | https://doi.org/10.1371/journal.pbio.2002940 December 7, 2017 32 / 34
61. Sanada K, Okano T, Fukada Y. Mitogen-activated protein kinase phosphorylates and negatively regu-
lates basic helix-loop-helix-PAS transcription factor BMAL1. J Biol Chem. 2002; 277(1):267–71. Epub
2001/11/01. https://doi.org/10.1074/jbc.M107850200 PMID: 11687575.
62. Orchard S, Ammari M, Aranda B, Breuza L, Briganti L, Broackes-Carter F, et al. The MIntAct project—
IntAct as a common curation platform for 11 molecular interaction databases. Nucleic acids research.
2013:gkt1115.
63. Pizarro A, Hayer K, Lahens NF, Hogenesch JB. CircaDB: a database of mammalian circadian gene
expression profiles. Nucleic acids research. 2012:gks1161.
64. Lehmann R, Childs L, Thomas P, Abreu M, Fuhr L, Herzel H, et al. Assembly of a comprehensive regu-
latory network for the mammalian circadian clock: a bioinformatics approach. PLoS ONE. 2015; 10(5):
e0126283. https://doi.org/10.1371/journal.pone.0126283 PMID: 25945798
65. Razick S, Magklaras G, Donaldson IM. iRefIndex: a consolidated protein interaction database with prov-
enance. BMC bioinformatics. 2008; 9(1):405.
66. Kojima H, Inoue T, Kunimoto H, Nakajima K. IL-6-STAT3 signaling and premature senescence. Jak-
stat. 2013; 2(4):e25763. https://doi.org/10.4161/jkst.25763 PMID: 24416650
67. Althubiti M, Lezina L, Carrera S, Jukes-Jones R, Giblett S, Antonov A, et al. Characterization of novel
markers of senescence and their prognostic potential in cancer. Cell death & disease. 2014; 5(11):
e1528.
68. Lee S, Schmitt CA, Reimann M, editors. The Myc/macrophage tango: oncogene-induced senescence,
Myc style. Seminars in cancer biology; 2011: Elsevier.
69. Courtois-Cox S, Williams SMG, Reczek EE, Johnson BW, McGillicuddy LT, Johannessen CM, et al. A
negative feedback signaling network underlies oncogene-induced senescence. Cancer cell. 2006; 10
(6):459–72. https://doi.org/10.1016/j.ccr.2006.10.003 PMID: 17157787
70. Reimann M, Lee S, Loddenkemper C, Do¨rr JR, Tabor V, Aichele P, et al. Tumor stroma-derived TGF-β
limits myc-driven lymphomagenesis via Suv39h1-dependent senescence. Cancer cell. 2010; 17
(3):262–72. https://doi.org/10.1016/j.ccr.2009.12.043 PMID: 20227040
71. Kennedy AL, Morton JP, Manoharan I, Nelson DM, Jamieson NB, Pawlikowski JS, et al. Activation of
the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote
tumorigenesis. Molecular cell. 2011; 42(1):36–49. https://doi.org/10.1016/j.molcel.2011.02.020 PMID:
21474066
72. Woller A, Duez H, Staels B, Lefranc M. A mathematical model of the liver circadian clock linking feeding
and fasting cycles to clock function. Cell reports. 2016; 17(4):1087–97. https://doi.org/10.1016/j.celrep.
2016.09.060 PMID: 27760313
73. Chin L, Pomerantz J, Polsky D, Jacobson M, Cohen C, Cordon-Cardo C, et al. Cooperative effects of
INK4a and ras in melanoma susceptibility in vivo. Genes Dev. 1997; 11(21):2822–34. PMID: 9353252
74. Khapre RV, Kondratova AA, Susova O, Kondratov RV. Circadian clock protein BMAL1 regulates cellu-
lar senescence in vivo. Cell cycle. 2011; 10(23):4162–9. https://doi.org/10.4161/cc.10.23.18381 PMID:
22101268
75. Kiessling S, Beaulieu-Laroche L, Blum ID, Landgraf D, Welsh DK, Storch KF, et al. Enhancing circadian
clock function in cancer cells inhibits tumor growth. BMC Biol. 2017; 15(1):13. https://doi.org/10.1186/
s12915-017-0349-7 PMID: 28196531
76. Todaro GJ, Green H. Quantitative studies of the growth of mouse embryo cells in culture and their
development into established lines. The Journal of cell biology. 1963; 17(2):299–313.
77. Sporl F, Schellenberg K, Blatt T, Wenck H, Wittern KP, Schrader A, et al. A circadian clock in HaCaT
keratinocytes. J Invest Dermatol. 2011; 131(2):338–48. https://doi.org/10.1038/jid.2010.315 PMID:
20962856.
78. Lu¨ck S, Thurley K, Thaben PF, Westermark PO. Rhythmic degradation explains and unifies circadian
transcriptome and proteome data. Cell reports. 2014; 9(2):741–51. https://doi.org/10.1016/j.celrep.
2014.09.021 PMID: 25373909
79. Watson JV, Chambers SH, Smith PJ. A pragmatic approach to the analysis of DNA histograms with a
definable G1 peak. Cytometry. 1987; 8(1):1–8. https://doi.org/10.1002/cyto.990080101 PMID: 3803091
80. Carvalho BS, Irizarry RA. A framework for oligonucleotide microarray preprocessing. Bioinformatics.
2010; 26(19):2363–7. https://doi.org/10.1093/bioinformatics/btq431 PMID: 20688976
81. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normali-
zation, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003; 4
(2):249–64. https://doi.org/10.1093/biostatistics/4.2.249 PMID: 12925520.
82. Gu Z. ComplexHeatmap: Making Complex Heatmaps. In: Gu Z, editor. 1.60 ed2015.
Ink4a/Arf: A switch-like mechanism for circadian regulation via RAS
PLOS Biology | https://doi.org/10.1371/journal.pbio.2002940 December 7, 2017 33 / 34
83. Kauffmann A, Gentleman R, Huber W. arrayQualityMetrics—a bioconductor package for quality
assessment of microarray data. Bioinformatics. 2009; 25(3):415–6. https://doi.org/10.1093/
bioinformatics/btn647 PMID: 19106121
84. Huntley MA, Larson JL, Chaivorapol C, Becker G, Lawrence M, Hackney JA, et al. ReportingTools: an
automated result processing and presentation toolkit for high-throughput genomic analyses. Bioinfor-
matics. 2013; 29(24):3220–1. https://doi.org/10.1093/bioinformatics/btt551 PMID: 24078713.
85. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analy-
ses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47. https://doi.org/
10.1093/nar/gkv007 PMID: 25605792
86. Huang H, Liu Y, Marron J. sigclust: Statistical Significance of Clustering. R package version: 1.0. 0.
2012.
87. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environ-
ment for integrated models of biomolecular interaction networks. Genome research. 2003; 13
(11):2498–504. https://doi.org/10.1101/gr.1239303 PMID: 14597658
Ink4a/Arf: A switch-like mechanism for circadian regulation via RAS
PLOS Biology | https://doi.org/10.1371/journal.pbio.2002940 December 7, 2017 34 / 34
